{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":70,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":70,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"d78694197d76","filters":{"venue":"Clinical Neuropharmacology"}},"results":[{"id":"W2025416757","doi":"10.1097/00002826-200109000-00002","title":"Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms","year":2001,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":730,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Spinal cord injury; Excitotoxicity; Neuroprotection; Pathophysiology; Neuroscience; Ischemia; Intensive care medicine; Spinal cord; Pathology; Internal medicine; Psychology; Psychiatry; Glutamate receptor","authors":[{"name":"Randall J. Dumont","is_ca":true},{"name":"David O. Okonkwo","is_ca":false},{"name":"Subodh Verma","is_ca":true},{"name":"R. John Hurlbert","is_ca":true},{"name":"Paul T. Boulos","is_ca":false},{"name":"Dilantha B. Ellegala","is_ca":false},{"name":"Aaron S. Dumont","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3255204422491643,"gpt":0.587321250806737,"spread":0.2618008085575728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000441469,0.001491799,0.001660523,0.001507095,0.0004113837,0.001390111,0.0009885319,0.001720149,0.003122669],"category_scores_gemma":[0.0004613243,0.0002916396,0.0003995331,0.002079775,0.00123182,0.00182288,0.0005414315,0.001465067,0.002973934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008134589,"about_ca_system_score_gemma":0.001390919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001076265,"about_ca_topic_score_gemma":0.001130145,"domain_scores_codex":[0.9997427,0.00004929423,0.0000486016,0.00005005374,0.00008879614,0.00002050299],"domain_scores_gemma":[0.9997509,0.00009296971,0.00004570379,0.00001012479,0.00007716528,0.0000231906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009272496,0.0002547602,0.0006620315,0.02076234,0.00005170577,0.0006762042,0.0001823528,0.0004318505,0.008595185,0.005248685,0.02664633,0.9363958],"study_design_scores_gemma":[0.00004290091,0.0006198105,0.006801613,0.006675585,0.0001325301,0.0101709,0.0003719114,0.0002097779,0.002796286,0.01158039,0.9605544,0.00004392456],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001858845,0.9977075,0.0002608804,0.0002886794,0.0001965403,0.00001297521,0.00001056598,0.000009527541,0.001327527],"genre_scores_gemma":[0.0009253027,0.9976364,0.0002204867,0.0001533335,0.0003122772,0.00001499216,0.00001636343,9.799181e-7,0.00071976],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003122669,"threshold_uncertainty_score":0.01044631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007751663","doi":"10.1097/wnf.0000000000000016","title":"Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease","year":2014,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cannabis; Medicine; Rating scale; McGill Pain Questionnaire; Parkinson's disease; Disease; Observational study; Physical therapy; Visual analogue scale; Psychiatry; Psychology; Internal medicine","authors":[{"name":"Itay Lotan","is_ca":false},{"name":"T. A. Treves","is_ca":false},{"name":"Yaniv Roditi","is_ca":false},{"name":"Ruth Djaldetti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03197668711806857,"gpt":0.3959902137891548,"spread":0.3640135266710862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002039498,0.0001416994,0.0003961399,0.00022668,0.0003956706,0.0001660218,0.0001625822,0.0002399894,0.001752619],"category_scores_gemma":[0.0006300311,0.00007216668,0.0002632428,0.0002107618,0.0001795001,0.0001197058,0.0001541703,0.0002860768,0.0001998768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000255942,"about_ca_system_score_gemma":0.0003400461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001587805,"about_ca_topic_score_gemma":0.00674786,"domain_scores_codex":[0.9998029,0.00006968268,0.00002370061,0.00002052823,0.00005246649,0.00003081799],"domain_scores_gemma":[0.9997638,0.00005371899,0.00009902347,0.000008869819,0.00002318944,0.00005133048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03137215,0.01256632,0.4172599,0.003560927,0.001178825,0.003190536,0.0009023506,0.0004520634,0.0575364,0.0002633742,0.002657035,0.4690601],"study_design_scores_gemma":[0.001644139,0.02141351,0.9641481,0.000197788,0.0002451203,0.003595493,0.0003176569,0.000501127,0.003463057,0.0001185445,0.004332509,0.00002295838],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895045,0.008723335,0.00008041108,0.0001501066,0.00002287036,0.00008394923,0.00009983956,0.000009531169,0.001325507],"genre_scores_gemma":[0.9968117,0.002440163,0.0001784704,0.00006901472,0.00002625488,0.0000238767,0.00006339383,9.583873e-7,0.0003861893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001752619,"threshold_uncertainty_score":0.00586307,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2088003671","doi":"10.1097/00002826-200109000-00003","title":"Acute Spinal Cord Injury, Part II: Contemporary Pharmacotherapy","year":2001,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Spinal cord injury; Methylprednisolone; Pharmacology; Spinal cord; Anesthesia","authors":[{"name":"Randall J. Dumont","is_ca":true},{"name":"Subodh Verma","is_ca":true},{"name":"David O. Okonkwo","is_ca":false},{"name":"R. John Hurlbert","is_ca":true},{"name":"Paul T. Boulos","is_ca":false},{"name":"Dilantha B. Ellegala","is_ca":false},{"name":"Aaron S. Dumont","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4288615500723238,"gpt":0.6179216795098523,"spread":0.1890601294375285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006355431,0.0006640434,0.0009301902,0.001937696,0.0004056778,0.00184915,0.0006271725,0.001107457,0.006744015],"category_scores_gemma":[0.0009808022,0.0002112109,0.0004958265,0.001844588,0.0007433259,0.001503006,0.0008426174,0.002178861,0.002549712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001122463,"about_ca_system_score_gemma":0.001387093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527868,"about_ca_topic_score_gemma":0.003359526,"domain_scores_codex":[0.9996663,0.00008932511,0.00005472486,0.00005377961,0.0001041322,0.00003167592],"domain_scores_gemma":[0.999599,0.0001223721,0.00006813591,0.0000248798,0.0001276264,0.00005798823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001335613,0.0003077292,0.0004876579,0.004400264,0.00006835801,0.0001808809,0.0001058363,0.000375055,0.001252357,0.006970813,0.03780983,0.9479076],"study_design_scores_gemma":[0.0001220823,0.0005729002,0.006413832,0.006659501,0.0001229153,0.002621257,0.0002286082,0.0004416142,0.000568127,0.009368706,0.972843,0.00003756664],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001162728,0.9782814,0.0009707463,0.006350462,0.0009021081,0.00006637935,0.00006532786,0.0000390513,0.01216193],"genre_scores_gemma":[0.004757259,0.9853657,0.00126274,0.003289027,0.00164405,0.00009007502,0.00009817262,0.00001170433,0.003481109],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006744015,"threshold_uncertainty_score":0.02256101,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980626997","doi":"10.1097/wnf.0b013e31804c780e","title":"Gambling and Increased Sexual Desire With Dopaminergic Medications in Restless Legs Syndrome","year":2007,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Pramipexole; Ropinirole; Restless legs syndrome; Dopaminergic; Psychology; Levodopa; Parkinson's disease; Mania; Psychiatry; Dopamine agonist; Disease; Medicine; Internal medicine; Dopamine; Bipolar disorder; Neuroscience; Neurology; Mood","authors":[{"name":"Erika Driver‐Dunckley","is_ca":false},{"name":"Brie N. Noble","is_ca":false},{"name":"Joseph G. Hentz","is_ca":false},{"name":"Virgilio Gerald H. Evidente","is_ca":true},{"name":"John N. Caviness","is_ca":false},{"name":"James M. Parish","is_ca":false},{"name":"Lois E. Krahn","is_ca":false},{"name":"Charles H. Adler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1106238907938104,"gpt":0.4626233068166211,"spread":0.3519994160228107,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005991285,0.0001455014,0.0002252499,0.0005284983,0.000168163,0.0003593346,0.0001415539,0.0003393702,0.001709645],"category_scores_gemma":[0.003333879,0.0001210274,0.0003952079,0.0003958149,0.0002674591,0.0003561486,0.0002867614,0.0003216094,0.0001293798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001647305,"about_ca_system_score_gemma":0.0001505645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001288694,"about_ca_topic_score_gemma":0.002405342,"domain_scores_codex":[0.9995694,0.0001845155,0.00006543517,0.0000362261,0.0001013688,0.00004305633],"domain_scores_gemma":[0.9982978,0.0004968947,0.0009255096,0.00002906456,0.00009646385,0.0001542458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007689484,0.00004211537,0.9967878,0.00002709272,0.000035155,0.0001953675,0.00006748038,0.00002796521,0.0001155593,0.00000798463,0.0000479965,0.002568679],"study_design_scores_gemma":[0.000008757187,0.0001947654,0.9976337,0.00001418366,0.00002001781,0.001666599,0.0001589026,0.0001479003,0.00005282378,0.00001318871,0.00008641072,0.000002761185],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990817,0.0003287915,0.00003846575,0.00006647851,0.000003473658,0.00000887005,0.00006125351,0.000001406713,0.0004095308],"genre_scores_gemma":[0.999666,0.0001289495,0.00004160357,0.00004457746,0.000007383931,0.000002864701,0.00005264564,2.861933e-7,0.00005563065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001709645,"threshold_uncertainty_score":0.005719304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039313127","doi":"10.1097/00002826-200203000-00010","title":"Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease With Modafinil","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Epworth Sleepiness Scale; Modafinil; Parkinson's disease; Dopamine agonist; Dopaminergic; Excessive daytime sleepiness; Medicine; Levodopa; Psychology; Internal medicine; Anesthesia; Dopamine; Disease; Psychiatry; Sleep disorder; Polysomnography; Insomnia","authors":[{"name":"Anette Nieves","is_ca":true},{"name":"Anthony E. Lang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03507027948667208,"gpt":0.318900012094994,"spread":0.2838297326083219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676732,0.0004437272,0.00115754,0.0002355393,0.0004409336,0.0002907928,0.000288798,0.000464967,0.000818277],"category_scores_gemma":[0.001088881,0.000164899,0.0004575134,0.0002340979,0.0003102145,0.0002753639,0.000184023,0.0005837646,0.0001648968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002756489,"about_ca_system_score_gemma":0.0002940116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005820756,"about_ca_topic_score_gemma":0.002251006,"domain_scores_codex":[0.999815,0.00006036787,0.00003551515,0.00002259731,0.00003165058,0.00003483902],"domain_scores_gemma":[0.9995943,0.0001232568,0.0001024493,0.00001985659,0.00002227891,0.0001378868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.12611,0.01418114,0.3582979,0.001884986,0.001336813,0.005933494,0.0009257403,0.001151457,0.08391198,0.0002710232,0.004805894,0.4011897],"study_design_scores_gemma":[0.03095823,0.136017,0.8118622,0.0001491353,0.0004073803,0.007606944,0.0003169354,0.001869417,0.003687547,0.0002716174,0.006804227,0.00004937048],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952296,0.003366989,0.0001492191,0.0001409086,0.00004102245,0.0001335954,0.00005734727,0.00001800484,0.0008633984],"genre_scores_gemma":[0.9969026,0.001555517,0.0005327342,0.0003508789,0.0001129366,0.0001256886,0.0001647098,0.000003049073,0.0002517846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00115754,"threshold_uncertainty_score":0.003002167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248937293","doi":"10.1097/00002826-200001000-00007","title":"A Randomized Controlled Trial Comparing Pramipexole with Levodopa in Early Parkinson's Disease: Design and Methods of the CALM-PD Study","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pramipexole; Levodopa; Tolerability; Parkinson's disease; Medicine; Randomized controlled trial; Entacapone; Placebo; Dopaminergic; Clinical trial; Psychology; Internal medicine; Disease; Adverse effect; Dopamine","authors":[{"name":"Parkinson Study Group","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06708977375762877,"gpt":0.4175193602424132,"spread":0.3504295864847844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02260589,0.004720983,0.008305431,0.001464527,0.0009717423,0.002264841,0.00165044,0.004855968,0.01305349],"category_scores_gemma":[0.02465725,0.00178899,0.004670499,0.001362347,0.002583024,0.002080583,0.001300502,0.003809654,0.002163287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001324846,"about_ca_system_score_gemma":0.004085413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173644,"about_ca_topic_score_gemma":0.001700751,"domain_scores_codex":[0.9764127,0.01869959,0.00119424,0.001647647,0.001035986,0.001009907],"domain_scores_gemma":[0.9885034,0.006675803,0.001682266,0.001035997,0.0008401015,0.001262405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9860973,0.004262425,0.0004157595,0.0007341129,0.001593254,0.00003264546,0.00004911036,0.0003562109,0.0003308939,0.0006092165,0.000429228,0.005089687],"study_design_scores_gemma":[0.9751956,0.02216152,0.0003036947,0.00003244019,0.00069985,0.000007923872,0.000009913382,0.0004713792,0.00007282064,0.0003122715,0.0007198352,0.00001279993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"methods","genre_scores_codex":[0.4348584,0.01123967,0.01568982,0.003354173,0.007132111,0.5124976,0.004600105,0.0006614514,0.009966753],"genre_scores_gemma":[0.4112511,0.004021625,0.03072472,0.00396618,0.002548543,0.5357186,0.002103955,0.00009726472,0.009567924],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02260589,"threshold_uncertainty_score":0.1195529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047508973","doi":"10.1097/00002826-200601000-00009","title":"Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Research Unit on Children's Psychosocial Maladjustment","funders":"","keywords":"Clozapine; Schizophrenia (object-oriented programming); Antipsychotic; Medicine; Clinical trial; Refractory (planetary science); Psychiatry; Antipsychotic Agent; Psychology; Internal medicine","authors":[{"name":"Fayçal Mouaffak","is_ca":false},{"name":"Constantin Tranulis","is_ca":false},{"name":"Raphaël Gourévitch","is_ca":false},{"name":"Marie‐France Poirier","is_ca":false},{"name":"S. Douki","is_ca":true},{"name":"Jean-Pierre Oli","is_ca":false},{"name":"Henri L o","is_ca":false},{"name":"David Gourion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1417854540866392,"gpt":0.4910354738667544,"spread":0.3492500197801152,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001168204,0.0006920841,0.001601598,0.002598732,0.0002036082,0.0005339231,0.0008903378,0.0007422069,0.001771733],"category_scores_gemma":[0.001608865,0.0002641109,0.0008904082,0.002375592,0.0003819994,0.0005337743,0.0003527369,0.0004279954,0.0003641118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005820861,"about_ca_system_score_gemma":0.001189545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001980861,"about_ca_topic_score_gemma":0.004998188,"domain_scores_codex":[0.9994844,0.0002147424,0.0001142538,0.00004446738,0.0001210648,0.0000210058],"domain_scores_gemma":[0.9992907,0.0004447532,0.0001686107,0.0000133262,0.00005687962,0.00002585463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007204404,0.00009960555,0.0005030677,0.1384379,0.0009497564,0.0006643106,0.0001777103,0.0003147182,0.002013348,0.0007041821,0.004289723,0.8511254],"study_design_scores_gemma":[0.002233265,0.002947785,0.02145493,0.1402319,0.0140395,0.01975489,0.001031091,0.0007728211,0.006309056,0.002732791,0.7883445,0.0001475229],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004637543,0.9992455,0.00002455969,0.00003546677,0.00002001806,0.00000742621,0.0000042918,0.000002491087,0.000196501],"genre_scores_gemma":[0.004321295,0.9952686,0.0002058803,0.00006497623,0.00003491106,0.00001348409,0.00001083818,7.193351e-7,0.00007911095],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002598732,"threshold_uncertainty_score":0.006178141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W44850464","doi":"10.1097/wnf.0b013e3180340319","title":"The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease","year":2007,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Duloxetine; McGill Pain Questionnaire; Duloxetine Hydrochloride; Visual analogue scale; Parkinson's disease; Brief Pain Inventory; Rating scale; Medicine; Quality of life (healthcare); Physical therapy; Psychology; Disease; Chronic pain; Internal medicine","authors":[{"name":"Ruth Djaldetti","is_ca":false},{"name":"Shlomit Yust‐Katz","is_ca":false},{"name":"Vadim Kolianov","is_ca":false},{"name":"Eldad Melamed","is_ca":false},{"name":"Ron Dabby","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01790105886594781,"gpt":0.3595551155893931,"spread":0.3416540567234453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001973393,0.0002745908,0.0007364237,0.0001196596,0.0001812749,0.0001659688,0.000187942,0.0003404105,0.002109283],"category_scores_gemma":[0.0007651311,0.00008373357,0.0002561852,0.0001063224,0.0001668401,0.0001162676,0.00008244503,0.0003578886,0.0001827408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002074036,"about_ca_system_score_gemma":0.0001915133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009864086,"about_ca_topic_score_gemma":0.004273194,"domain_scores_codex":[0.9998575,0.0000540551,0.00001379992,0.000011767,0.00003197086,0.00003081521],"domain_scores_gemma":[0.9997191,0.00009877081,0.00006837662,0.000008537273,0.00002824401,0.00007692535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1532055,0.01361954,0.08115887,0.004814851,0.001747931,0.002052362,0.0004574968,0.0007776232,0.1559896,0.000113332,0.003252273,0.5828105],"study_design_scores_gemma":[0.02722227,0.2104134,0.7425623,0.0002295265,0.001143981,0.002923891,0.0002866595,0.00112801,0.01040089,0.00009761447,0.003557882,0.00003366639],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992905,0.005512828,0.00005368813,0.0001217868,0.00003178299,0.00006453589,0.00008539431,0.00001469773,0.001210259],"genre_scores_gemma":[0.9974247,0.001715955,0.0001661345,0.0001325568,0.00006221945,0.00003277693,0.0000967115,0.00000155917,0.0003673842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002109283,"threshold_uncertainty_score":0.007056296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018810282","doi":"10.1097/00002826-200105000-00005","title":"Double-blind, Crossover, Placebo-controlled Trial of Bromocriptine in Patients with Sleep Bruxism","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Temporomandibular Joint Disorders","field":"Health Professions","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Bromocriptine; Placebo; Crossover study; Medicine; Sleep Bruxism; Anesthesia; Internal medicine; Electromyography; Hormone; Prolactin; Physical medicine and rehabilitation","authors":[{"name":"Gilles Lavigne","is_ca":true},{"name":"Jean‐Paul Soucy","is_ca":false},{"name":"Frank Lobbezoo","is_ca":false},{"name":"Christiane Manzini","is_ca":true},{"name":"Pierre J. Blanchet","is_ca":true},{"name":"Jacques Montplaisir","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08322264891113389,"gpt":0.461242579060787,"spread":0.3780199301496531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329645,0.001520754,0.005071274,0.0005697186,0.0006124519,0.0008083631,0.0008556463,0.002418556,0.00517059],"category_scores_gemma":[0.002008109,0.0007468082,0.001067866,0.0004358489,0.00123657,0.0009164385,0.0003463571,0.002031964,0.0009424441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004337749,"about_ca_system_score_gemma":0.0008651979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005588998,"about_ca_topic_score_gemma":0.001057336,"domain_scores_codex":[0.9992368,0.0003514681,0.00007868901,0.0001572275,0.00006513191,0.0001105533],"domain_scores_gemma":[0.9990065,0.0003270986,0.0001476289,0.00009038784,0.00009064802,0.0003378301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9664133,0.008492027,0.0005649586,0.0005755124,0.000477603,0.00005216879,0.000058505,0.0001463771,0.004951485,0.00005929973,0.0004672395,0.0177416],"study_design_scores_gemma":[0.9121834,0.08463429,0.001936792,0.00001453486,0.0001551738,0.00002358178,0.00001552479,0.0001670381,0.000344638,0.00004434359,0.00047071,0.000009998429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825759,0.007547473,0.001001563,0.0006186425,0.0009897784,0.004312125,0.0006715768,0.0002311467,0.00205186],"genre_scores_gemma":[0.9840836,0.00283714,0.00194189,0.001123149,0.0009349108,0.006148176,0.0006890504,0.00002634891,0.002215749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00517059,"threshold_uncertainty_score":0.01729733,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980632974","doi":"10.1097/wnf.0b013e31827db49b","title":"Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease","year":2013,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Parkwood Institute","funders":"","keywords":"Medicine; Adverse effect; Pharmacokinetics; Placebo; Anesthesia; Pharmacodynamics; Cerebrospinal fluid; Gastroenterology; Internal medicine; Pathology","authors":[{"name":"Jaren W. Landen","is_ca":false},{"name":"Qinying Zhao","is_ca":false},{"name":"Sharon Cohen","is_ca":false},{"name":"Michael Borrie","is_ca":true},{"name":"Mark Woodward","is_ca":false},{"name":"Clare B. Billing","is_ca":false},{"name":"Kelly R. Bales","is_ca":false},{"name":"Christine Alvey","is_ca":false},{"name":"Fred McCush","is_ca":false},{"name":"Jerry Yang","is_ca":false},{"name":"James W. Kupiec","is_ca":false},{"name":"Martin M. Bednar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05818489725870915,"gpt":0.3828051632185218,"spread":0.3246202659598126,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006363704,0.0006944835,0.001303026,0.00019891,0.0002785491,0.0004307026,0.0004361737,0.0008690399,0.001836842],"category_scores_gemma":[0.001012881,0.000285905,0.0004334346,0.0001300971,0.0004648713,0.0004879878,0.0001602231,0.001236856,0.0004650211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003672442,"about_ca_system_score_gemma":0.0005247461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004215771,"about_ca_topic_score_gemma":0.0007867523,"domain_scores_codex":[0.999709,0.0001121905,0.00001569382,0.0000678393,0.00004559895,0.00004960026],"domain_scores_gemma":[0.9995658,0.00009984213,0.000132975,0.00004148522,0.00003825751,0.0001216242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6045213,0.04186816,0.01033014,0.0007116608,0.0007245761,0.0003486275,0.0002332179,0.001153416,0.1617801,0.00008494601,0.001028003,0.1772158],"study_design_scores_gemma":[0.1404508,0.7947584,0.04574204,0.00003477231,0.0004136501,0.00057761,0.00005944227,0.001386209,0.01510139,0.00008351186,0.001361649,0.00003061443],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984884,0.000634959,0.0002119779,0.0000510224,0.00002461395,0.0002052402,0.0000683713,0.00003577318,0.000279658],"genre_scores_gemma":[0.998624,0.0002568382,0.0003362894,0.00007301748,0.00004792742,0.0001692641,0.00009391514,0.000004595461,0.000394191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001836842,"threshold_uncertainty_score":0.006144822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045089703","doi":"10.1097/00002826-200307000-00013","title":"Metabolite Changes Resulting From Treatment in Children With ADHD: A 1H-MRS Study","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Institute for Biodiagnostics; Dalhousie University; Izaak Walton Killam Health Centre; Nova Scotia Health Authority","funders":"Eli Lilly Canada; Nova Scotia Health Research Foundation","keywords":"Phosphocreatine; Creatine; Glutamine; Metabolite; Striatum; Choline; Glutamate receptor; Neurochemical; Internal medicine; Glutamatergic; Attention deficit hyperactivity disorder; Medicine; Endocrinology; Ventral striatum; Psychology; Chemistry; Biochemistry; Dopamine; Psychiatry; Amino acid","authors":[{"name":"Normand Carrey","is_ca":true},{"name":"Frank P. MacMaster","is_ca":true},{"name":"Joshua Fogel","is_ca":false},{"name":"Sandra J. Sparkes","is_ca":true},{"name":"Daniel A. Waschbusch","is_ca":true},{"name":"S. O' Sullivan","is_ca":true},{"name":"Mathias V. Schmidt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1213473788737947,"gpt":0.4435567764725035,"spread":0.3222093975987088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001888913,0.0003978266,0.0007978932,0.0005074046,0.0006284682,0.0003162237,0.0002089062,0.0006678378,0.0007955518],"category_scores_gemma":[0.001055992,0.0003296724,0.0004126421,0.0005867223,0.0004617991,0.0002044981,0.0002113446,0.0007607591,0.0001594191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008468755,"about_ca_system_score_gemma":0.000452099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01047211,"about_ca_topic_score_gemma":0.01345426,"domain_scores_codex":[0.9997566,0.00004789104,0.00002259582,0.00004020603,0.00007074139,0.0000618094],"domain_scores_gemma":[0.999662,0.00006122312,0.0001461138,0.00001397916,0.00005098051,0.00006567532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002952866,0.001012277,0.9450971,0.000183,0.0002855318,0.007209879,0.001208815,0.0002038555,0.02525712,0.00004212136,0.0003792336,0.01616823],"study_design_scores_gemma":[0.00006985883,0.001464625,0.9877416,0.000009689374,0.0001422642,0.006617029,0.0005032394,0.0001198335,0.002748397,0.00001837565,0.0005552372,0.00000990482],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993969,0.0002169739,0.00005389958,0.00002817826,0.000002770284,0.000009585817,0.00008684408,0.000004273136,0.0002006453],"genre_scores_gemma":[0.99882,0.0003365591,0.0002880215,0.00005759847,0.000008848804,0.00001699418,0.0002465884,0.000005192254,0.0002201881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01047211,"threshold_uncertainty_score":0.02082235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980849388","doi":"10.1097/01.wnf.0000174932.82134.e2","title":"Quetiapine for Insomnia in Parkinson Disease","year":2005,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Quetiapine; Pittsburgh Sleep Quality Index; Epworth Sleepiness Scale; Insomnia; Internal medicine; Medicine; Excessive daytime sleepiness; Rating scale; Polysomnography; Hypnotic; Psychology; Anesthesia; Sleep disorder; Psychiatry; Schizophrenia (object-oriented programming); Sleep quality","authors":[{"name":"Carlos Juri","is_ca":true},{"name":"Pedro Chaná","is_ca":true},{"name":"John Frederick D. Tapia","is_ca":true},{"name":"Carolina Kunstmann","is_ca":true},{"name":"Teresa Parrao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1265459834756793,"gpt":0.5002710878749101,"spread":0.3737251043992308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003852452,0.0003256649,0.000858422,0.0001988649,0.0002279087,0.0002439193,0.000314218,0.0004486611,0.001269809],"category_scores_gemma":[0.0006535794,0.00007892882,0.0004684553,0.0002094481,0.000216898,0.0001687274,0.0001030519,0.0005469465,0.0002515166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000282881,"about_ca_system_score_gemma":0.000311712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001140219,"about_ca_topic_score_gemma":0.003597956,"domain_scores_codex":[0.9998496,0.00006654808,0.00001537341,0.00001483077,0.00003056991,0.00002311234],"domain_scores_gemma":[0.999764,0.0000756392,0.00005059121,0.0000103776,0.00001612779,0.00008332462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2151207,0.009132589,0.02476891,0.002569891,0.001236157,0.00223381,0.0002558597,0.0007280121,0.0856372,0.0004059749,0.005299046,0.6526118],"study_design_scores_gemma":[0.2405857,0.3239386,0.3723072,0.0004544575,0.001946817,0.008360346,0.0002146838,0.003987449,0.01949566,0.0007882227,0.02783891,0.0000819027],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.97013,0.02557955,0.0005442592,0.0003055682,0.0001437896,0.000268347,0.0001884375,0.00009264478,0.002747508],"genre_scores_gemma":[0.9857488,0.01079986,0.0007689786,0.000410485,0.0002145718,0.0001373752,0.0003891073,0.00001100504,0.001519897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001269809,"threshold_uncertainty_score":0.004247963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W117490009","doi":"10.1097/wnf.0b013e3181c46f48","title":"A Prospective, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Type A Botulinum Toxins Botox and Prosigne in the Treatment of Cervical Dystonia","year":2010,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Spasmodic Torticollis; Medicine; Tolerability; Randomized controlled trial; Botulinum toxin; Dystonia; Quality of life (healthcare); Adverse effect; Anesthesia; Torticollis; Rating scale; Surgery; Internal medicine; Psychology","authors":[{"name":"Elizabeth Maria Aparecida Barasnevicius Quagliato","is_ca":false},{"name":"Edmur Franco Carelli","is_ca":false},{"name":"Maura Aparecida Viana","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06563286935701265,"gpt":0.396070542860635,"spread":0.3304376735036223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005400877,0.001849397,0.004763143,0.0007111829,0.001097205,0.001109304,0.001122103,0.002987902,0.005115306],"category_scores_gemma":[0.006653572,0.001422589,0.001737602,0.0007494389,0.002883881,0.001409709,0.0006030644,0.002449059,0.0008747639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006841149,"about_ca_system_score_gemma":0.002578155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007762767,"about_ca_topic_score_gemma":0.001177794,"domain_scores_codex":[0.9959083,0.002455734,0.0004205777,0.000497515,0.0003921124,0.0003257357],"domain_scores_gemma":[0.9944122,0.002343823,0.00111168,0.0005409895,0.0004540698,0.001137226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9791444,0.0125083,0.0004751503,0.0002458476,0.0003810385,0.00002411006,0.00003617286,0.0001021261,0.00201931,0.00005855693,0.0001001621,0.004904918],"study_design_scores_gemma":[0.8613983,0.136879,0.0009434254,0.00001181511,0.0001949995,0.00001368721,0.000009349171,0.0001211686,0.0002322492,0.00004102888,0.0001446052,0.00001035068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866279,0.002231337,0.0009567741,0.0002252277,0.0004882983,0.008053028,0.0004290887,0.0000695222,0.0009187803],"genre_scores_gemma":[0.9766226,0.002068257,0.003913994,0.001082765,0.0009342252,0.01276508,0.0007117836,0.00002876359,0.001872597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005400877,"threshold_uncertainty_score":0.0285629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018391979","doi":"10.1097/00002826-200007000-00005","title":"Sustained Cabergoline Treatment Reverses Levodopa-Induced Dyskinesias in Parkinsonian Monkeys","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Cabergoline; Benserazide; Dyskinesia; Levodopa; Dopamine; Medicine; Parkinson's disease; MPTP; Decarboxylase inhibitor; Dopamine agonist; Agonist; Dopamine receptor D2; Internal medicine; Anesthesia; Pharmacology; Endocrinology; Receptor; Dopaminergic; Disease; Prolactin","authors":[{"name":"Abdallah Hadj Tahar","is_ca":true},{"name":"Laurent Grégoire","is_ca":true},{"name":"Evelyne Bangassoro","is_ca":true},{"name":"Paul J. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06180993642833334,"gpt":0.3893135241711484,"spread":0.3275035877428151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001095356,0.0003978936,0.0004998575,0.0003347751,0.0002445889,0.0003079059,0.0002407163,0.000422347,0.0004341901],"category_scores_gemma":[0.0001781304,0.0001695741,0.0002305195,0.0001021523,0.0002564249,0.0001761064,0.0001427417,0.0006098427,0.0002560162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003890956,"about_ca_system_score_gemma":0.0002445173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001676483,"about_ca_topic_score_gemma":0.0038549,"domain_scores_codex":[0.9998757,0.00002087761,0.0000123173,0.00002004907,0.00001846441,0.00005263675],"domain_scores_gemma":[0.9998168,0.00002283126,0.00005261222,0.00002117883,0.00002057026,0.00006605669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006122668,0.0001935544,0.0005182295,0.00003509194,0.00001121575,0.0001151421,0.000043149,0.00004169609,0.9961259,0.00002025447,0.00003397464,0.00224959],"study_design_scores_gemma":[0.0004531826,0.01678831,0.03749119,0.00003325383,0.0001310507,0.0008935989,0.0001594718,0.001768717,0.9388109,0.00009559914,0.003355875,0.00001886472],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987519,0.0006071148,0.0001447103,0.00002961653,0.00001093916,0.00001571895,0.00006456868,0.00003528875,0.000340117],"genre_scores_gemma":[0.9972872,0.0005762072,0.0005160977,0.00004407626,0.00001797406,0.0000485513,0.0002918659,0.00001943939,0.001198781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001676483,"threshold_uncertainty_score":0.003333509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943068831","doi":"10.1097/wnf.0000000000000344","title":"Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study","year":2019,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Curcumin; Schizophrenia (object-oriented programming); Placebo; Antipsychotic; Positive and Negative Syndrome Scale; Medicine; Internal medicine; Adverse effect; Randomized controlled trial; Depression (economics); Psychiatry; Clinical trial; Psychology; Psychosis; Pharmacology","authors":[{"name":"Chanoch Miodownik","is_ca":false},{"name":"Vladimir Lerner","is_ca":false},{"name":"Natalie Kudkaeva","is_ca":false},{"name":"Paul P. Lerner","is_ca":false},{"name":"Artashez Pashinian","is_ca":false},{"name":"Yuly Bersudsky","is_ca":false},{"name":"Ronen Eliyahu","is_ca":false},{"name":"Anatoly Kreinin","is_ca":false},{"name":"Joseph Bergman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02028843139327818,"gpt":0.3621573988056611,"spread":0.3418689674123829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001964431,0.001523758,0.005060863,0.000903377,0.000653827,0.0007944687,0.0008450888,0.002096148,0.004987729],"category_scores_gemma":[0.001745698,0.0008816246,0.001954549,0.0006697014,0.001404485,0.001012342,0.0005101332,0.001727807,0.0005281324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006328898,"about_ca_system_score_gemma":0.00156724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009790009,"about_ca_topic_score_gemma":0.00265387,"domain_scores_codex":[0.99914,0.00035847,0.0001191895,0.0001683599,0.0001098641,0.0001040565],"domain_scores_gemma":[0.9987663,0.0002815996,0.0003320269,0.0001030331,0.0001780276,0.0003389951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9661508,0.01343341,0.0006338706,0.002105082,0.001229053,0.00005281018,0.00005127254,0.00008432438,0.003684759,0.00002725493,0.0003280039,0.01221939],"study_design_scores_gemma":[0.9021613,0.09317745,0.002573184,0.00006337879,0.0009647793,0.00002726434,0.00002475009,0.0001299196,0.0003672467,0.00003439446,0.0004562247,0.00002003777],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742964,0.01494804,0.0006193975,0.0004640533,0.0008649214,0.007118342,0.0007242647,0.0001301035,0.000834499],"genre_scores_gemma":[0.9729006,0.01148198,0.00269275,0.001159303,0.001088281,0.007880145,0.0006115976,0.00002251428,0.002162908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005060863,"threshold_uncertainty_score":0.01668555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052643285","doi":"10.1097/00002826-200107000-00003","title":"Methylphenidate Increases the Motor Effects of L-Dopa in Parkinson's Disease: A Pilot Study","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Methylphenidate; Anxiety; Levodopa; Anesthesia; Psychology; Dyskinesia; Mood; Dopamine; Placebo; Carbidopa; Stroop effect; Medicine; Parkinson's disease; Cognition; Psychiatry; Internal medicine; Attention deficit hyperactivity disorder; Neuroscience; Disease","authors":[{"name":"Richard Camicioli","is_ca":true},{"name":"Eric S. Lea","is_ca":false},{"name":"John G. Nutt","is_ca":false},{"name":"Gary Sexton","is_ca":false},{"name":"Barry Oken","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05245199753721957,"gpt":0.3818614101433815,"spread":0.329409412606162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005395095,0.0008159874,0.001268856,0.0002682308,0.0004184158,0.000339323,0.0004549253,0.000811422,0.002239047],"category_scores_gemma":[0.0007330442,0.0002642582,0.0006711115,0.0002210588,0.000443244,0.0004414989,0.000267015,0.0009862657,0.0004035588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002667913,"about_ca_system_score_gemma":0.0004962655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001593731,"about_ca_topic_score_gemma":0.003838751,"domain_scores_codex":[0.9997697,0.00008738134,0.00002296737,0.00002718735,0.00003976592,0.00005288289],"domain_scores_gemma":[0.9996025,0.000109362,0.0000480225,0.00003051914,0.00003702065,0.0001725508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3646559,0.04527314,0.01604121,0.001113637,0.001355077,0.003109147,0.0004062234,0.0003365791,0.4259714,0.0000972647,0.00103963,0.1406008],"study_design_scores_gemma":[0.06568446,0.7622157,0.1229081,0.00006603261,0.001396319,0.002314058,0.0001911118,0.0007552824,0.03985333,0.00008932763,0.004484416,0.00004184546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971973,0.00174836,0.00009037701,0.00007431502,0.00003844027,0.0001536913,0.0001016902,0.00001754486,0.0005783692],"genre_scores_gemma":[0.9971086,0.001422809,0.000299662,0.000139448,0.00008379152,0.0001002161,0.0002905715,0.000006744685,0.000548063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002239047,"threshold_uncertainty_score":0.007490337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2920938584","doi":"10.1097/wnf.0000000000000326","title":"Real-World Experience With VMAT2 Inhibitors","year":2019,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dystonia Medical Research Foundation Canada; WiLAN (Canada)","funders":"","keywords":"Tetrabenazine; Tics; Medicine; Medical prescription; Dose; Internal medicine; Vesicular monoamine transporter; Pediatrics; Psychiatry; Monoamine neurotransmitter; Pharmacology; Dopamine","authors":[{"name":"Nicki Niemann","is_ca":false},{"name":"Joseph Jankovic","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06645725897481558,"gpt":0.4016426721567979,"spread":0.3351854131819824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001250723,0.0001564686,0.0002010567,0.0004156267,0.000585391,0.001043251,0.0005038816,0.0004631414,0.002558118],"category_scores_gemma":[0.01038794,0.000175474,0.000304622,0.0006095466,0.0005795139,0.001076655,0.0007696434,0.0006517196,0.0003922106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008839525,"about_ca_system_score_gemma":0.0007857865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002587684,"about_ca_topic_score_gemma":0.004254114,"domain_scores_codex":[0.9980551,0.0008504787,0.0002486072,0.0002274325,0.0004163975,0.0002018706],"domain_scores_gemma":[0.9916427,0.001963471,0.004556397,0.0001898993,0.0006628667,0.0009847343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005102092,0.0004798758,0.855395,0.0008994205,0.0002790612,0.01144299,0.01173808,0.001083571,0.00204453,0.000914261,0.009576487,0.1056366],"study_design_scores_gemma":[0.0001406625,0.002744937,0.6512074,0.001224139,0.0003765726,0.1968837,0.02441516,0.002677384,0.003411554,0.0006676405,0.1160687,0.0001821861],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755713,0.01311988,0.000976833,0.002383832,0.00008109418,0.0000308096,0.0003399724,0.00004260719,0.007453705],"genre_scores_gemma":[0.991723,0.00581707,0.0006366537,0.0008593953,0.000108618,0.0000142219,0.0002258499,0.000020519,0.00059453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002587684,"threshold_uncertainty_score":0.008557737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993332355","doi":"10.1097/00002826-200401000-00008","title":"Effect of Riluzole on Dyskinesia and Duration of the ON State in Parkinson Disease Patients","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Riluzole; Dyskinesia; Placebo; Levodopa; Apomorphine; Parkinson's disease; Anesthesia; Medicine; Psychology; Amyotrophic lateral sclerosis; Internal medicine; Disease; Dopaminergic; Dopamine","authors":[{"name":"Claudia Aparecida Braz","is_ca":true},{"name":"Vanderci Borges","is_ca":false},{"name":"Henrique Ballalai Ferraz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0163435614235081,"gpt":0.3469000184184506,"spread":0.3305564569949425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000365616,0.0003783869,0.000859081,0.0001712772,0.0001614982,0.0002670209,0.0001646892,0.0003127515,0.0007994461],"category_scores_gemma":[0.00104603,0.00009930431,0.0004219283,0.0001249411,0.0001467121,0.0001981969,0.0001271194,0.000378271,0.0001438763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001944323,"about_ca_system_score_gemma":0.0001243551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004766601,"about_ca_topic_score_gemma":0.001530397,"domain_scores_codex":[0.9997683,0.0001143438,0.00003063916,0.00002153306,0.00003406955,0.00003108672],"domain_scores_gemma":[0.9995029,0.0001758049,0.0001232614,0.00002584686,0.000049404,0.0001226687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1928544,0.009535142,0.214745,0.001224058,0.002441898,0.00136998,0.0005840309,0.0007610521,0.1549771,0.0001384612,0.001174114,0.4201948],"study_design_scores_gemma":[0.009691263,0.1739237,0.7968069,0.00009613845,0.001251904,0.001835685,0.0002825515,0.001044224,0.01158833,0.00008368864,0.003351844,0.00004370944],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958217,0.002956272,0.00005368351,0.00004237257,0.00001571378,0.00002652635,0.00005005405,0.000008178684,0.001025521],"genre_scores_gemma":[0.9983647,0.0008634108,0.0001656762,0.0000903433,0.00003358414,0.00002110113,0.0001491989,0.000002355367,0.0003094983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000859081,"threshold_uncertainty_score":0.002674401,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2882844","doi":"","title":"Role of Remote Sensing in Disaster Management","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Synthetic Aperture Radar (SAR) Applications and Techniques","field":"Engineering","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute for Catastrophic Loss Reduction","keywords":"Remote sensing; Emergency management; Computer science; Business; Computer security; Geography; Political science","authors":[{"name":"Nirupama","is_ca":false},{"name":"Slobodan P. Simonović","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02484973261665826,"gpt":0.304537285211696,"spread":0.2796875525950377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003049458,0.0006290331,0.0005534772,0.002027458,0.0005896917,0.003315486,0.0008778964,0.001175098,0.003668977],"category_scores_gemma":[0.003488891,0.0002169452,0.0003277783,0.002665761,0.001793432,0.002983455,0.001724553,0.001328001,0.001035268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008484222,"about_ca_system_score_gemma":0.001062593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002943112,"about_ca_topic_score_gemma":0.00173248,"domain_scores_codex":[0.9981114,0.001008947,0.00008135143,0.0002169111,0.0005010943,0.00008030564],"domain_scores_gemma":[0.996658,0.002076759,0.0002813585,0.0002569209,0.0006118649,0.0001151488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001108043,0.0001161224,0.01108921,0.002314185,0.0001326713,0.0006070355,0.001039056,0.02136288,0.003790086,0.1080217,0.02948481,0.8219315],"study_design_scores_gemma":[0.00002113521,0.0004039068,0.0197432,0.003734825,0.0001100342,0.00128807,0.005574067,0.04152318,0.00371772,0.1782936,0.7453755,0.0002148734],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04482729,0.4313377,0.2047075,0.04641351,0.004882999,0.0004015835,0.001534241,0.00123495,0.2646603],"genre_scores_gemma":[0.6328703,0.222271,0.1216361,0.003670158,0.00295656,0.000143588,0.0007706761,0.0001663176,0.01551536],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003668977,"threshold_uncertainty_score":0.01612729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963544666","doi":"10.1097/wnf.0b013e31819a68b5","title":"Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia","year":2009,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Aripiprazole; Schizophrenia (object-oriented programming); Positive and Negative Syndrome Scale; Neurocognitive; Wisconsin Card Sorting Test; Psychology; Brief Psychiatric Rating Scale; Akathisia; Rating scale; Scale for the Assessment of Negative Symptoms; Psychiatry; Cognition; Trail Making Test; Global Assessment of Functioning; Clinical psychology; Psychosis; Antipsychotic; Neuropsychology; Developmental psychology","authors":[{"name":"Sung‐Wan Kim","is_ca":false},{"name":"Il‐Seon Shin","is_ca":false},{"name":"Jae‐Min Kim","is_ca":false},{"name":"Jeong-Hoon Lee","is_ca":false},{"name":"Yo‐Han Lee","is_ca":false},{"name":"Sujin Yang","is_ca":false},{"name":"Jin‐Sang Yoon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02359581114582315,"gpt":0.3757193929095006,"spread":0.3521235817636775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005892591,0.0003015717,0.0008067971,0.0002316484,0.000413103,0.0004484761,0.0002254798,0.0005301271,0.0009283574],"category_scores_gemma":[0.002958527,0.000174718,0.000608723,0.0002125503,0.0001997242,0.0004152572,0.0001952442,0.0005161407,0.0001289177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004718924,"about_ca_system_score_gemma":0.0003984322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001613832,"about_ca_topic_score_gemma":0.003456847,"domain_scores_codex":[0.9996388,0.0001121652,0.00005825515,0.0000534766,0.0000895281,0.00004782118],"domain_scores_gemma":[0.9987913,0.0003244547,0.0004106999,0.00005315189,0.00009591549,0.0003245098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06710613,0.004850136,0.7499019,0.0004023607,0.001668354,0.0009361483,0.0007159527,0.0009498523,0.0106355,0.00002954568,0.0006103578,0.1621937],"study_design_scores_gemma":[0.002480133,0.0211743,0.972963,0.0000534989,0.0004527169,0.0006600244,0.0002905706,0.0006795813,0.0006258122,0.0000417037,0.0005505821,0.0000280045],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991696,0.0004982753,0.00001439671,0.00004388259,0.00001145917,0.00001338403,0.00004372998,0.000003726109,0.0002016269],"genre_scores_gemma":[0.9994199,0.0002164422,0.00005350345,0.00007882098,0.0000206684,0.00001260503,0.000136327,8.201824e-7,0.00006098468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001613832,"threshold_uncertainty_score":0.00342381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109594309","doi":"10.1097/01.wnf.0000236763.16032.60","title":"Plasma Homocysteine Levels and Parkinson Disease","year":2006,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Internal medicine; Montreal Cognitive Assessment; Medicine; Homocysteine; Parkinson's disease; Depression (economics); Psychosis; Dementia; Rating scale; Beck Depression Inventory; Gastroenterology; Disease; Psychology; Psychiatry","authors":[{"name":"Sharon Hassin‐Baer","is_ca":false},{"name":"Oren S. Cohen","is_ca":false},{"name":"Eli Vakil","is_ca":false},{"name":"Ben‐Ami Sela","is_ca":false},{"name":"Zeev Nitsan","is_ca":false},{"name":"Roseline Schwartz","is_ca":false},{"name":"Joab Chapman","is_ca":false},{"name":"David Tanné","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07257440747081113,"gpt":0.413837142456368,"spread":0.3412627349855569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002399869,0.0002478772,0.0003910245,0.000488625,0.0003046766,0.0004420516,0.0001055302,0.0005280189,0.001754758],"category_scores_gemma":[0.001177316,0.0001236841,0.0001124892,0.0004191068,0.0001691275,0.000174838,0.0001900241,0.000325064,0.000217335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001530912,"about_ca_system_score_gemma":0.0001424309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007925946,"about_ca_topic_score_gemma":0.0009435676,"domain_scores_codex":[0.9998178,0.00004593031,0.00003196944,0.00004491604,0.00003837932,0.00002102732],"domain_scores_gemma":[0.9992571,0.0001882103,0.0003274507,0.000015229,0.00009456535,0.0001173684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001148014,0.00008904751,0.9883377,0.0001017656,0.0001411704,0.0004895951,0.0001242607,0.00006830812,0.00244246,0.00002127471,0.0001991927,0.006837127],"study_design_scores_gemma":[0.00001842277,0.0003133038,0.9972593,0.00001967048,0.00004803006,0.001584071,0.00006351938,0.0001113898,0.0002684971,0.00002976066,0.0002803526,0.000003806844],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963416,0.002907969,0.00004711139,0.00005206373,0.000005903857,0.00000402724,0.0001625116,0.000004852699,0.0004739536],"genre_scores_gemma":[0.9990662,0.0003993806,0.0001204642,0.00003661976,0.00001503888,0.000005709445,0.0001689102,0.000001230086,0.0001864987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001754758,"threshold_uncertainty_score":0.005870283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033461129","doi":"10.1097/00002826-200309000-00006","title":"Lamotrigine Treatment for Post-Stroke Pathological Laughing and Crying","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Infant Health and Development","field":"Health Professions","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Lamotrigine; Crying; Stroke (engine); Medicine; Mood; Pathological; Anesthesia; Serotonin reuptake inhibitor; Epilepsy; Psychology; Pediatrics; Antidepressant; Psychiatry; Internal medicine","authors":[{"name":"Rajamannar Ramasubbu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2165462839635849,"gpt":0.5531428008630249,"spread":0.33659651689944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001519356,0.0002824668,0.0004690563,0.0003465512,0.0005657805,0.0001043989,0.0002629877,0.0006734286,0.001497091],"category_scores_gemma":[0.000847956,0.00008774866,0.0003301911,0.0001999414,0.0002144107,0.0001298328,0.0001982139,0.0006085777,0.0003764774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004704045,"about_ca_system_score_gemma":0.000399994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001473715,"about_ca_topic_score_gemma":0.005286562,"domain_scores_codex":[0.9998897,0.00003257622,0.00001271457,0.000006686753,0.00001751964,0.00004068057],"domain_scores_gemma":[0.9998707,0.00003540981,0.00003026683,0.000008195844,0.00001480403,0.00004071294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.007101055,0.00210783,0.02687575,0.001963647,0.000313398,0.1496541,0.001164682,0.0005601057,0.08634827,0.0009810911,0.01654183,0.7063884],"study_design_scores_gemma":[0.006160478,0.02769315,0.3582562,0.0007275786,0.0008170219,0.4338797,0.001512273,0.003074447,0.07163297,0.00215294,0.09399928,0.00009390785],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9506998,0.02960029,0.001926187,0.005160038,0.00028858,0.0001895534,0.00009562381,0.0003520329,0.011688],"genre_scores_gemma":[0.9878405,0.008185682,0.0008174654,0.000893218,0.0001879184,0.00005681309,0.0001057757,0.00001241039,0.001900198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001497091,"threshold_uncertainty_score":0.00500828,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049816046","doi":"10.1097/00002826-200201000-00005","title":"A Double-Blind Crossover, Placebo-Controlled Study of the Adenosine A2A Antagonist Theophylline in Parkinson's Disease","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Theophylline; Crossover study; Antagonist; Placebo; Medicine; Adenosine; Double blind; Anesthesia; Pharmacology; Internal medicine; Pathology","authors":[{"name":"Jaime Kulisevsky","is_ca":true},{"name":"Manel J. Barbanoj","is_ca":false},{"name":"Alexandre Gironell","is_ca":true},{"name":"Rosa Antonijoan","is_ca":false},{"name":"Miguel Casas","is_ca":false},{"name":"Berta Pascual‐Sedano","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05653257955031033,"gpt":0.3572882097378645,"spread":0.3007556301875541,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002374088,0.001691694,0.004523976,0.000704304,0.0008572245,0.0007771027,0.0008479918,0.00221386,0.003886844],"category_scores_gemma":[0.002645954,0.0007382921,0.0009544538,0.0005783433,0.001996035,0.001173844,0.0004107033,0.002147122,0.0007526496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004425293,"about_ca_system_score_gemma":0.0009556026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005266831,"about_ca_topic_score_gemma":0.0007968302,"domain_scores_codex":[0.9987141,0.0005585587,0.0001509951,0.000295423,0.0001183619,0.000162655],"domain_scores_gemma":[0.9984017,0.0005446283,0.0002577709,0.0001495867,0.0001333349,0.0005129496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9431593,0.0266192,0.0006794633,0.0005935609,0.0004904961,0.00004838383,0.0001220656,0.0001484197,0.01064158,0.00009068612,0.00042002,0.01698669],"study_design_scores_gemma":[0.7153955,0.2780758,0.003973602,0.00002109974,0.0002425452,0.00003480332,0.00002700331,0.0002795045,0.001133609,0.000100695,0.0006962843,0.00001950473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874527,0.003580391,0.0011397,0.000316207,0.0008143074,0.004676462,0.0005760886,0.0001668044,0.001277287],"genre_scores_gemma":[0.9844227,0.00214623,0.002849854,0.0007847801,0.0008837373,0.005770242,0.000674435,0.00003168088,0.002436237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004523976,"threshold_uncertainty_score":0.01300281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028210993","doi":"10.1097/wnf.0b013e3181ac155b","title":"Milnacipran","year":2009,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McGill University","keywords":"Milnacipran; Fibromyalgia; Antidepressant; Reuptake inhibitor; Pharmacology; Venlafaxine; Duloxetine; Tolerability; Psychology; Medicine; Internal medicine; Psychiatry; Anxiety; Adverse effect","authors":[{"name":"Chi‐Un Pae","is_ca":false},{"name":"David M. Marks","is_ca":false},{"name":"Manan Shah","is_ca":false},{"name":"Byung‐Joo Ham","is_ca":false},{"name":"Ashwin A. Patkar","is_ca":false},{"name":"Prakash S. Masand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2960391119950188,"gpt":0.5823993394174389,"spread":0.2863602274224202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001801171,0.000859479,0.0009896636,0.001626455,0.000217687,0.0005830725,0.0007347065,0.0006945927,0.006386014],"category_scores_gemma":[0.0003204938,0.000187553,0.0003840452,0.001159081,0.0001893728,0.0006673043,0.0005251369,0.001158518,0.004209433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002992769,"about_ca_system_score_gemma":0.000396175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006291017,"about_ca_topic_score_gemma":0.001265005,"domain_scores_codex":[0.9998572,0.00002576976,0.00002130906,0.00002721175,0.00005440381,0.00001417398],"domain_scores_gemma":[0.9999286,0.00002204038,0.00002064675,0.000003091258,0.00001530372,0.00001036691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001756183,0.00009410593,0.00009052271,0.009904386,0.00008778867,0.0002315009,0.00003452751,0.0001325452,0.003106503,0.001095321,0.0197858,0.9652613],"study_design_scores_gemma":[0.0001133146,0.0002069365,0.001230235,0.00229869,0.0001311845,0.002475944,0.00002951904,0.00009922001,0.002296525,0.0008398762,0.9902596,0.00001900575],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006892118,0.9927625,0.000335499,0.000232123,0.0002764485,0.00003125999,0.00007231894,0.00004698847,0.005553697],"genre_scores_gemma":[0.004922305,0.9879048,0.0008019618,0.0006451261,0.0002259066,0.00004670044,0.0002684176,0.000006379738,0.005178331],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006386014,"threshold_uncertainty_score":0.02136332,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005346374","doi":"10.1097/00002826-200007000-00003","title":"Mexiletine in the Treatment of Torticollis and Generalized Dystonia","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Mexiletine; Dystonia; Medicine; Anesthesia; Torticollis; Rating scale; Trihexyphenidyl; Adverse effect; Psychology; Internal medicine; Surgery; Psychiatry","authors":[{"name":"Claudio Lucetti","is_ca":false},{"name":"Angelo Nuti","is_ca":false},{"name":"Gianna Gambaccini","is_ca":false},{"name":"Silvia Bernardini","is_ca":false},{"name":"Stefania Brotini","is_ca":false},{"name":"Maria Laura Manca","is_ca":false},{"name":"Ubaldo Bonuccelli","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05272901068265193,"gpt":0.395296412991609,"spread":0.342567402308957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002339015,0.0002633189,0.0005302239,0.0001619998,0.0001483713,0.00009009385,0.0001606869,0.0002196363,0.0008888176],"category_scores_gemma":[0.0005173876,0.00006068768,0.0002292624,0.0001521416,0.000173823,0.0001048815,0.0001493064,0.0003744972,0.00009339372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001729241,"about_ca_system_score_gemma":0.0001726848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001154606,"about_ca_topic_score_gemma":0.003618817,"domain_scores_codex":[0.9998885,0.00005689374,0.00001197252,0.00001064405,0.00001640167,0.00001553283],"domain_scores_gemma":[0.9998397,0.00005681168,0.00004433665,0.0000102104,0.000008604728,0.00004040094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02733378,0.002991736,0.0278777,0.002368672,0.0006539082,0.01140284,0.0006940711,0.001881768,0.1969911,0.0003995961,0.002223092,0.7251816],"study_design_scores_gemma":[0.0211651,0.2116093,0.6852356,0.0003329648,0.000822501,0.02823185,0.0003669955,0.003501864,0.02718294,0.0003750967,0.0210817,0.00009403407],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854253,0.01178839,0.0003545239,0.0001732532,0.00002455412,0.00006742169,0.00003850363,0.00003328419,0.002094738],"genre_scores_gemma":[0.9956849,0.003266028,0.0004129116,0.0001064505,0.00004158659,0.00002288885,0.00007180852,0.000003298048,0.0003901554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001154606,"threshold_uncertainty_score":0.002973437,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084409189","doi":"10.1097/00002826-200005000-00003","title":"The Relationship between COMT Genotype and the Clinical Effectiveness of Tolcapone, a COMT Inhibitor, in Patients with Parkinson's Disease","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Catechol-O-methyl transferase; Genotype; Levodopa; Internal medicine; Parkinson's disease; Clinical trial; Gastroenterology; Medicine; Psychology; Disease; Biology; Genetics; Gene","authors":[{"name":"Derek J. Chong","is_ca":true},{"name":"Oksana Suchowersky","is_ca":true},{"name":"Carol L. Szumlanski","is_ca":false},{"name":"Richard M. Weinshilboum","is_ca":false},{"name":"Norm R.C. Campbell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04146685183536344,"gpt":0.3644804545033011,"spread":0.3230136026679377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007640808,0.0002947365,0.0005034063,0.0002804804,0.000240154,0.0004498404,0.0001550524,0.0004667615,0.0005737582],"category_scores_gemma":[0.004089499,0.0001954599,0.0003942395,0.0003155283,0.0001964966,0.0002751471,0.0001491702,0.0004300899,0.0001546962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002979903,"about_ca_system_score_gemma":0.0001370927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009589581,"about_ca_topic_score_gemma":0.001912882,"domain_scores_codex":[0.9993715,0.0002493835,0.0001073728,0.00009956498,0.0001167026,0.00005546977],"domain_scores_gemma":[0.9967218,0.001414847,0.001078381,0.0002050081,0.0002214316,0.0003585003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005588816,0.0001892368,0.9831005,0.00002683923,0.0004117574,0.0002250657,0.00007186824,0.0003515052,0.002284168,0.000009071954,0.00008389054,0.007657299],"study_design_scores_gemma":[0.00006858759,0.001472199,0.9972379,0.00000292827,0.00009330341,0.0003764039,0.00003089734,0.0003611157,0.0002551074,0.00001474361,0.00008147558,0.000005317269],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993008,0.0003750828,0.00004287139,0.00002945842,0.000004850704,0.000003592526,0.00005546362,0.000002791796,0.0001850147],"genre_scores_gemma":[0.999681,0.00006123498,0.00004934951,0.00002091554,0.000006809606,0.00000238776,0.00007749491,0.000001298146,0.00009963819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009589581,"threshold_uncertainty_score":0.004040897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977455030","doi":"10.1097/01.wnf.0000220817.94102.95","title":"The Controversy Concerning Plasma Homocysteine in Parkinson Disease Patients Treated with Levodopa Alone or with Entacapone","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Entacapone; Levodopa; Catechol-O-methyl transferase; Parkinson's disease; Homocysteine; Hyperhomocysteinemia; Concomitant; Medicine; Plasma homocysteine; Internal medicine; Pharmacology; Endocrinology; Psychology; Disease; Chemistry; Biochemistry; Genotype","authors":[{"name":"Theresa A. Zesiewicz","is_ca":true},{"name":"Lynn Wecker","is_ca":false},{"name":"Kelly L. Sullivan","is_ca":true},{"name":"Lisa R. Merlin","is_ca":false},{"name":"Robert A. Hauser","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09628879543517495,"gpt":0.4267736520732911,"spread":0.3304848566381162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00147617,0.0004714534,0.002914491,0.001887369,0.0003202784,0.001233693,0.001099114,0.001745665,0.001784382],"category_scores_gemma":[0.002467233,0.0002452853,0.0006208502,0.00240995,0.0007230937,0.001149197,0.0004928159,0.001389857,0.0008813609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007191234,"about_ca_system_score_gemma":0.001458058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001428527,"about_ca_topic_score_gemma":0.002431108,"domain_scores_codex":[0.9995073,0.0001390959,0.0001365211,0.00007785238,0.0001173662,0.00002187408],"domain_scores_gemma":[0.9991372,0.0005153486,0.0001333507,0.00001588069,0.0001661446,0.00003202101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003388841,0.00003452996,0.0004664374,0.04082967,0.0003225206,0.0005727937,0.0001686374,0.00007443948,0.0009557416,0.001672843,0.01948229,0.9350812],"study_design_scores_gemma":[0.0002276024,0.0003674892,0.005022862,0.04199795,0.00173127,0.007886352,0.0005267714,0.00006587424,0.001107088,0.003248613,0.9377704,0.00004776707],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007840191,0.9993305,0.00001346395,0.0003186052,0.00007216334,9.854381e-7,0.000003918997,0.000001028208,0.0001810335],"genre_scores_gemma":[0.0008441958,0.998502,0.00006434859,0.0003310732,0.0001308157,0.000003794401,0.00000940924,5.416664e-7,0.0001137852],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002914491,"threshold_uncertainty_score":0.007806838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032852860","doi":"10.1097/00002826-200207000-00005","title":"Cognitive Deficits and Striatal Dopaminergic Denervation in Parkinson's Disease: A Single Photon Emission Computed Tomography Study Using 123Iodine-β-CIT in Patients ON and OFF Levodopa","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital","funders":"","keywords":"Dopaminergic; Parkinson's disease; Levodopa; Cognition; Denervation; Psychology; Neuroscience; Executive functions; Single-photon emission computed tomography; Audiology; Medicine; Internal medicine; Disease; Dopamine","authors":[{"name":"Nicole Duchesne","is_ca":false},{"name":"Jean‐Paul Soucy","is_ca":true},{"name":"Hélène Masson","is_ca":true},{"name":"Sylvain Chouinard","is_ca":true},{"name":"Marc‐André Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0769197879628581,"gpt":0.3460114822832213,"spread":0.2690916943203632,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001761341,0.0006806127,0.0006380624,0.0009622423,0.0007241626,0.0004045343,0.0002537148,0.0008289306,0.001233037],"category_scores_gemma":[0.0007859943,0.0004094783,0.0004502782,0.0005753039,0.0005601413,0.0003344122,0.0003158088,0.0005871698,0.0002075114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003853719,"about_ca_system_score_gemma":0.0002645938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005779921,"about_ca_topic_score_gemma":0.006053478,"domain_scores_codex":[0.9998934,0.00001370353,0.0000166571,0.00002783985,0.00002420273,0.00002419234],"domain_scores_gemma":[0.9995492,0.0001053902,0.00009438897,0.0000240242,0.00005116426,0.0001758618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004553098,0.001213676,0.9685421,0.00005674823,0.0001678087,0.008912056,0.0008439768,0.0001769958,0.01047699,0.00003428807,0.00009629697,0.004925907],"study_design_scores_gemma":[0.00006651712,0.001961897,0.9910429,0.000004246174,0.00005565377,0.005870773,0.0002584625,0.0001876791,0.000414518,0.00002401491,0.0001038275,0.000009474942],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9997007,0.00006607138,0.00001662653,0.00000605393,0.000001363993,0.000005291704,0.00003534024,0.000001295942,0.0001674504],"genre_scores_gemma":[0.9995814,0.00006448994,0.00004804416,0.00002021613,0.000005816723,0.000007027712,0.0001117272,9.007309e-7,0.0001603323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005779921,"threshold_uncertainty_score":0.01149255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087320487","doi":"10.1097/00002826-200203000-00002","title":"Treatment of Patients With Tardive Dystonia With Olanzapine","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Cervical dystonia; Dystonia; Olanzapine; Torticollis; Rating scale; Visual analogue scale; Anesthesia; Psychology; Medicine; Schizophrenia (object-oriented programming); Surgery; Psychiatry","authors":[{"name":"Claudio Lucetti","is_ca":false},{"name":"Giovanna R. Bellini","is_ca":false},{"name":"Angelo Nuti","is_ca":false},{"name":"Silvia Bernardini","is_ca":false},{"name":"Grazia Dell’Agnello","is_ca":false},{"name":"Armando Piccinni","is_ca":false},{"name":"Luca Maggi","is_ca":false},{"name":"Maria Laura Manca","is_ca":false},{"name":"Ubaldo Bonuccelli","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268668397250507,"gpt":0.3233205935032119,"spread":0.2806339095307068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003818372,0.0004599614,0.0009725981,0.0002144685,0.000399555,0.0002581538,0.0002648906,0.0003640999,0.0005772422],"category_scores_gemma":[0.00107454,0.0001550652,0.0004428166,0.0001821645,0.0002304678,0.0002335477,0.0001840278,0.0004662048,0.0001529358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004434048,"about_ca_system_score_gemma":0.0003567092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001226061,"about_ca_topic_score_gemma":0.003350167,"domain_scores_codex":[0.999797,0.00006805881,0.00003878529,0.00002708119,0.00003454803,0.00003456497],"domain_scores_gemma":[0.9996426,0.0000971417,0.00008922262,0.00003328274,0.00002718213,0.0001104761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.191467,0.01228406,0.2331996,0.001108597,0.001119512,0.01680823,0.00189041,0.001718581,0.2315994,0.0001951822,0.001744817,0.3068647],"study_design_scores_gemma":[0.02726346,0.2615318,0.6606722,0.0001319894,0.000843373,0.02097182,0.0009704535,0.003914465,0.01809524,0.0003006485,0.005179596,0.0001249484],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985896,0.000715629,0.0001356952,0.00004254338,0.00001237737,0.0000797201,0.00003509965,0.00001251114,0.000376726],"genre_scores_gemma":[0.9985763,0.0004047324,0.0005409963,0.0000922553,0.00002611635,0.00007192707,0.0001197101,0.000002906481,0.0001651385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001226061,"threshold_uncertainty_score":0.003217101,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039473736","doi":"10.1097/00002826-200403000-00009","title":"Antidepressants in the Treatment of Psychosis With Comorbid Depression in Parkinson Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Psychosis; Psychiatry; Comorbidity; Depression (economics); Exacerbation; Parkinson's disease; Psychotic depression; Antidepressant; Disease; Depressive symptoms; Medicine; Psychology; Anxiety; Internal medicine","authors":[{"name":"Valerie Voon","is_ca":true},{"name":"Anthony E. Lang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05626604801569,"gpt":0.3955811821773232,"spread":0.3393151341616332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005222477,0.0002167174,0.0004364172,0.0004125408,0.0003454512,0.000371206,0.0002662239,0.001237051,0.0006972177],"category_scores_gemma":[0.0009044994,0.0001679598,0.0003504052,0.0002920601,0.0002828117,0.0002379808,0.0003161562,0.0007101876,0.0002021663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004154455,"about_ca_system_score_gemma":0.0005001301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000919838,"about_ca_topic_score_gemma":0.004437667,"domain_scores_codex":[0.999686,0.000147025,0.00005472542,0.00001591225,0.00006416736,0.00003225344],"domain_scores_gemma":[0.9996746,0.0001269373,0.0001165251,0.000009912532,0.00002339449,0.00004864771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003462313,0.0008385078,0.0569888,0.004699121,0.0004782416,0.08478839,0.0009504157,0.00114575,0.01923368,0.003578025,0.009724918,0.8141119],"study_design_scores_gemma":[0.002874674,0.01057049,0.3089724,0.002782834,0.001242374,0.4812349,0.001514511,0.003431976,0.007878733,0.006019685,0.1733516,0.0001257925],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4275745,0.5287308,0.0024059,0.01320678,0.0009301969,0.0001614748,0.00009965931,0.0001198404,0.02677087],"genre_scores_gemma":[0.8886559,0.1039346,0.002429389,0.002442442,0.000733462,0.00004548628,0.00005783078,0.000005160185,0.001695575],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001237051,"threshold_uncertainty_score":0.003014266,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1824305151","doi":"10.1097/wnf.0b013e318059be76","title":"Add-on Therapy With Acetylcholinesterase Inhibitors for Memory Dysfunction in Schizophrenia","year":2007,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Donepezil; Rivastigmine; Neurocognitive; Schizophrenia (object-oriented programming); Galantamine; Randomized controlled trial; Placebo; Memory impairment; Psychology; Medicine; Verbal memory; Meta-analysis; Clinical trial; Cognition; Dementia; Psychiatry; Internal medicine","authors":[{"name":"Émmanuel Stip","is_ca":true},{"name":"Amir A. Sepehry","is_ca":true},{"name":"Sylvie Chouinard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.205014524744987,"gpt":0.4969339128382372,"spread":0.2919193880932501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009626953,0.0008548248,0.003767144,0.004902586,0.0003343309,0.002055377,0.001122735,0.001238239,0.006342707],"category_scores_gemma":[0.01819612,0.0005510944,0.007029864,0.002616026,0.0006455585,0.001301209,0.00110354,0.001266502,0.0005279206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0017827,"about_ca_system_score_gemma":0.002729514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002246679,"about_ca_topic_score_gemma":0.008706021,"domain_scores_codex":[0.9946474,0.002465268,0.001609412,0.000291094,0.0008502377,0.0001365163],"domain_scores_gemma":[0.9891059,0.006762803,0.00302377,0.0002543886,0.0006578841,0.0001951665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.01494678,0.0003417379,0.009738,0.6608227,0.0540213,0.0006591288,0.0002224322,0.0005802611,0.002739402,0.0009248382,0.00404895,0.2509545],"study_design_scores_gemma":[0.03105702,0.01306059,0.07119305,0.3811316,0.4380781,0.004058557,0.000727933,0.0008798502,0.003317183,0.004631035,0.05157457,0.0002905866],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01840494,0.9747742,0.0004834097,0.001359106,0.0005688673,0.001142637,0.0009054965,0.0000244357,0.002336866],"genre_scores_gemma":[0.1850037,0.8038625,0.003345326,0.003410823,0.0008867562,0.001318476,0.001491029,0.00001585694,0.0006655282],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009626953,"threshold_uncertainty_score":0.0509128,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054808759","doi":"10.1097/00002826-200305000-00005","title":"Medications and Substances as a Cause of Headache: A Systematic Review of the Literature","year":2003,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Etiology; Medicine; Intensive care medicine; Headaches; Identification (biology); Psychiatry; Biology","authors":[{"name":"Cory Toth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1112457628367054,"gpt":0.501474342080962,"spread":0.3902285792442566,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001205936,0.0008015786,0.002904359,0.006913516,0.0003848675,0.0009912447,0.000797094,0.0009862666,0.003663409],"category_scores_gemma":[0.004038152,0.0004091612,0.001450998,0.009948993,0.0004038883,0.001295766,0.0005287988,0.0003535564,0.0004483019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001015293,"about_ca_system_score_gemma":0.003961077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005763737,"about_ca_topic_score_gemma":0.01643381,"domain_scores_codex":[0.9987966,0.0003155203,0.0004678553,0.0001064754,0.0002690046,0.00004463431],"domain_scores_gemma":[0.9968107,0.001989811,0.0007504112,0.000034782,0.000353956,0.00006021529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004030704,0.00008199787,0.005197311,0.5959879,0.002678116,0.003642321,0.000563262,0.0002257508,0.0007223411,0.000503422,0.01236747,0.3776271],"study_design_scores_gemma":[0.0004690952,0.0008299297,0.05286074,0.5880871,0.03731852,0.02855364,0.002602815,0.0002931892,0.0009474639,0.0009944395,0.2869258,0.0001173301],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007768962,0.9986998,0.00003003729,0.00008423603,0.00005240125,0.00002452774,0.00007019991,0.000001745892,0.0002602082],"genre_scores_gemma":[0.003352361,0.996201,0.0001489728,0.0001029861,0.0000412328,0.00002539916,0.00003951763,4.42568e-7,0.0000880301],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006913516,"threshold_uncertainty_score":0.01225537,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2399313480","doi":"10.1097/wnf.0000000000000102","title":"Caffeine and Progression of Parkinson Disease","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Coffee research and impacts","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Caffeine; Medicine; Parkinson's disease; Disease; Neuroscience; Psychology; Internal medicine","authors":[{"name":"David K. Simon","is_ca":false},{"name":"Cai Wu","is_ca":false},{"name":"Barbara C. Tilley","is_ca":false},{"name":"Anne‐Marie Wills","is_ca":false},{"name":"Michael J. Aminoff","is_ca":false},{"name":"Jacquelyn Bainbridge","is_ca":false},{"name":"Robert A. Hauser","is_ca":false},{"name":"Jay S. Schneider","is_ca":false},{"name":"Saloni Sharma","is_ca":false},{"name":"Carlos Singer","is_ca":false},{"name":"Caroline M. Tanner","is_ca":false},{"name":"Daniel Truong","is_ca":false},{"name":"Pei Shieen Wong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1888840536484773,"gpt":0.5239963377592634,"spread":0.3351122841107861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000673583,0.0003427923,0.000348441,0.0008644995,0.0004206221,0.0004751373,0.0001825059,0.0003846894,0.001656796],"category_scores_gemma":[0.001953466,0.0001446295,0.0004041972,0.0006315034,0.0001859757,0.0002059298,0.0003153494,0.000401482,0.0001918485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005760895,"about_ca_system_score_gemma":0.0003936099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00618447,"about_ca_topic_score_gemma":0.01017121,"domain_scores_codex":[0.9996225,0.0001139264,0.00003960275,0.00008193408,0.0001020828,0.00003996821],"domain_scores_gemma":[0.9981685,0.0002011009,0.001156529,0.00005718844,0.0002486611,0.0001680884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007086486,0.0005239719,0.9301683,0.0005878798,0.001244313,0.0003125924,0.0002735632,0.000379937,0.007951799,0.0001760786,0.001106273,0.05018885],"study_design_scores_gemma":[0.00002943995,0.0005020224,0.9972714,0.00005269955,0.0001666494,0.0002140612,0.0000211445,0.0001140183,0.0003367437,0.00008008639,0.001205289,0.000006447453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9698302,0.02614342,0.0002336848,0.0002817462,0.00002488289,0.00004322144,0.0009851091,0.00003508025,0.002422821],"genre_scores_gemma":[0.9955432,0.002822999,0.000264851,0.00005629975,0.00002427522,0.00001245444,0.0005115307,0.000005151534,0.0007591839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00618447,"threshold_uncertainty_score":0.01229692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002651101","doi":"10.1097/wnf.0b013e318263163c","title":"Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia","year":2012,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Immunogenicity; Medicine; Botulinum toxin; Seroconversion; Adverse effect; Internal medicine; Clinical trial; Botulism; Spasmodic Torticollis; Antibody; Immunology; Surgery; Torticollis; Biology","authors":[{"name":"Robert Chinnapongse","is_ca":false},{"name":"Mark Lew","is_ca":false},{"name":"Joaquim J. Ferreira","is_ca":false},{"name":"Kristen Gullo","is_ca":false},{"name":"Paul R. Nemeth","is_ca":false},{"name":"Yuxin Zhang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07284874114159376,"gpt":0.4068194709946589,"spread":0.3339707298530652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00639117,0.0002166607,0.000409725,0.0002237656,0.0002200408,0.0003942013,0.0002653183,0.0004702714,0.0006420717],"category_scores_gemma":[0.004747881,0.0001392643,0.0007209376,0.0002124488,0.0003352386,0.0004852553,0.0002573176,0.000491474,0.0001279045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003790038,"about_ca_system_score_gemma":0.0003095197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003618113,"about_ca_topic_score_gemma":0.0004028431,"domain_scores_codex":[0.9981787,0.0008514074,0.0002819868,0.0001242244,0.0004679428,0.00009562857],"domain_scores_gemma":[0.9953015,0.00169959,0.002078338,0.0002077358,0.0004817847,0.0002309755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1446569,0.01620849,0.3044552,0.004730223,0.008541466,0.0008102628,0.0009337,0.003848174,0.1135444,0.0003251231,0.001046779,0.4008995],"study_design_scores_gemma":[0.00481099,0.2798256,0.6820362,0.0004592901,0.003120814,0.001606079,0.0001872341,0.001658593,0.0230982,0.0001377325,0.003021544,0.00003775743],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852341,0.01358558,0.0002427004,0.0001105731,0.0000243266,0.00006182276,0.00006402498,0.000005990189,0.0006708695],"genre_scores_gemma":[0.9982448,0.001292761,0.0001078547,0.00005691022,0.00003716369,0.00002775003,0.00008074823,0.00000148779,0.0001506829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00639117,"threshold_uncertainty_score":0.03380013,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2332272503","doi":"10.1097/wnf.0b013e3181f5a5f9","title":"Bupropion for Depression in Schizophrenia","year":2010,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bupropion; Positive and Negative Syndrome Scale; Psychiatry; Psychology; Extrapyramidal symptoms; Tolerability; Schizophrenia (object-oriented programming); Antidepressant; Antipsychotic; Major depressive disorder; Medicine; Psychosis; Internal medicine; Adverse effect; Mood","authors":[{"name":"Susanne Englisch","is_ca":false},{"name":"Dragoš Inta","is_ca":false},{"name":"Andrea Eer","is_ca":false},{"name":"Mathias Zink","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05490505063828417,"gpt":0.4442350276429075,"spread":0.3893299770046233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002667158,0.0002025075,0.0002273887,0.0001553351,0.0001801163,0.0001380241,0.0001045636,0.0002520545,0.00280761],"category_scores_gemma":[0.0004272225,0.00004754516,0.0002300531,0.0001150437,0.0001365221,0.000114021,0.0001640399,0.0002678595,0.0005226446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001261525,"about_ca_system_score_gemma":0.0002168858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001648528,"about_ca_topic_score_gemma":0.0007633741,"domain_scores_codex":[0.9998803,0.00004330499,0.0000183159,0.000007362813,0.00003000438,0.00002058151],"domain_scores_gemma":[0.9998679,0.00002791967,0.00006215666,0.000005862353,0.00001051909,0.00002564447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006429277,0.0008085663,0.04259507,0.002734464,0.00023902,0.0199075,0.0005852687,0.000239295,0.07119903,0.001527865,0.01376916,0.8399655],"study_design_scores_gemma":[0.008215757,0.03698964,0.5293975,0.002986128,0.0006893016,0.1996528,0.001249112,0.001311251,0.0194017,0.00300721,0.1970292,0.00007038556],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7711195,0.1953816,0.002130632,0.006465838,0.0006357817,0.0006342882,0.0003140284,0.0001255161,0.02319289],"genre_scores_gemma":[0.953416,0.03723094,0.001848282,0.00186739,0.0004992563,0.0002246177,0.0002854439,0.000007266412,0.004620656],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00280761,"threshold_uncertainty_score":0.00939244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970671532","doi":"10.1097/00002826-200309000-00004","title":"Poor Tolerability of a Transdermal Nicotine Treatment in Parkinson's Disease","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôtel-Dieu de Montréal; Hôtel-Dieu de Québec; Université du Québec à Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tolerability; Transdermal; Medicine; Nicotine; Nausea; Vomiting; Adverse effect; Anesthesia; Parkinson's disease; Pharmacology; Internal medicine; Disease","authors":[{"name":"Simon Lemay","is_ca":true},{"name":"Pierre J. Blanchet","is_ca":false},{"name":"Sylvain Chouinard","is_ca":false},{"name":"Hélène Masson","is_ca":false},{"name":"Valérie Soland","is_ca":false},{"name":"Marc‐André Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03115746267772081,"gpt":0.3604565407004209,"spread":0.3292990780227001,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001595617,0.0001543816,0.0006742184,0.0001029602,0.0002091916,0.0003006169,0.0001342161,0.0003477809,0.0008632442],"category_scores_gemma":[0.002726853,0.0001046916,0.0005523821,0.0001433554,0.0001709,0.000287772,0.0001061898,0.0004567189,0.0001881215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002418814,"about_ca_system_score_gemma":0.0001032733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000269141,"about_ca_topic_score_gemma":0.0005234802,"domain_scores_codex":[0.9993325,0.0002942932,0.00009710129,0.00005548114,0.0001913359,0.00002934839],"domain_scores_gemma":[0.9980672,0.0009915436,0.0005537999,0.00009984963,0.0001718604,0.000115721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04585792,0.002547196,0.1985471,0.001572623,0.002138275,0.002810008,0.00115725,0.002168207,0.1739727,0.0002355971,0.001748203,0.5672451],"study_design_scores_gemma":[0.004147665,0.163027,0.7786921,0.0001727923,0.001707114,0.01045842,0.0004919922,0.002973585,0.03016311,0.0004501187,0.007649063,0.00006704939],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942359,0.003676687,0.0006153691,0.0002234272,0.00002092773,0.00004596201,0.00009100696,0.0000209641,0.001069643],"genre_scores_gemma":[0.9987087,0.0005903397,0.000195605,0.0001426055,0.00002864264,0.00001709433,0.00008403042,0.000003855617,0.0002291178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001595617,"threshold_uncertainty_score":0.008438528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1923911528","doi":"10.1097/wnf.0000000000000101","title":"A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Allergan; Ipsen","keywords":"Medicine; Cervical dystonia; Confidence interval; Spasmodic Torticollis; Randomized controlled trial; Anesthesia; Botulinum toxin; Significant difference; Crossover study; Surgery; Torticollis; Internal medicine","authors":[{"name":"Alma Rystedt","is_ca":false},{"name":"Lena Zetterberg","is_ca":false},{"name":"Joachim Burman","is_ca":false},{"name":"Dag Nyholm","is_ca":false},{"name":"Anders Johansson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2577468131499699,"gpt":0.4951198360469998,"spread":0.2373730228970299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002093373,0.0006581845,0.001698482,0.0006428491,0.0001791297,0.0005832521,0.0007304609,0.00125441,0.002122882],"category_scores_gemma":[0.002575478,0.0005264435,0.001157114,0.000418768,0.0007152164,0.0007026089,0.0002975678,0.0007475505,0.0003126486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004852395,"about_ca_system_score_gemma":0.0004938041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003474122,"about_ca_topic_score_gemma":0.0004384874,"domain_scores_codex":[0.9980804,0.00100872,0.0001946955,0.0002630354,0.0003373389,0.0001158607],"domain_scores_gemma":[0.9986293,0.0005431371,0.0004854328,0.0001003028,0.0001068617,0.000134927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8426343,0.01279921,0.001625538,0.001513218,0.001213738,0.00009211923,0.0001945797,0.000583305,0.06981193,0.0003627175,0.000335943,0.06883343],"study_design_scores_gemma":[0.1751094,0.805515,0.006890348,0.00008488295,0.001267853,0.0001436377,0.00005957597,0.0006329487,0.009009155,0.0001163745,0.001134221,0.00003661883],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940661,0.003859122,0.000548004,0.00007525317,0.0001543038,0.0007250986,0.00007649489,0.0000252515,0.0004703501],"genre_scores_gemma":[0.9932178,0.00237552,0.002449938,0.0001693965,0.00015072,0.0008177016,0.000186081,0.00001011884,0.0006226307],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002122882,"threshold_uncertainty_score":0.01107097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095110740","doi":"10.1097/wnf.0b013e31802fa61a","title":"Oral Cholinesterase Inhibitor Add-on Therapy for Cognitive Enhancement in Schizophrenia","year":2007,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Louis-H Lafontaine; Université du Québec à Montréal","funders":"","keywords":"Neurocognitive; Schizophrenia (object-oriented programming); Cognition; Psychology; Executive functions; Physical medicine and rehabilitation; Medicine; Psychiatry","authors":[{"name":"Sylvie Chouinard","is_ca":true},{"name":"Amir A. Sepehry","is_ca":true},{"name":"Émmanuel Stip","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2847984843581851,"gpt":0.5543568871014394,"spread":0.2695584027432543,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005348172,0.0005168715,0.002308836,0.002966065,0.0002240395,0.001299815,0.0007080504,0.0009972265,0.005832344],"category_scores_gemma":[0.0140252,0.0002584131,0.003246221,0.001983628,0.0004839597,0.0006764956,0.0005838806,0.0009155492,0.0003405293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001405496,"about_ca_system_score_gemma":0.002225827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002111122,"about_ca_topic_score_gemma":0.007578349,"domain_scores_codex":[0.9971519,0.001482631,0.0007157062,0.0001537779,0.0004307623,0.00006526864],"domain_scores_gemma":[0.9934384,0.004463611,0.001627864,0.00009316456,0.0002876213,0.00008923723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00863378,0.0003505372,0.00344259,0.6441267,0.02455919,0.0003240189,0.0001441524,0.0005342101,0.00115272,0.001083889,0.003696894,0.3119513],"study_design_scores_gemma":[0.03149045,0.01131193,0.04779752,0.6234513,0.2184649,0.001758845,0.0006240472,0.001056879,0.002525916,0.004298231,0.05703519,0.0001848633],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01145254,0.9832041,0.0003422518,0.001142291,0.0002671886,0.0009683546,0.0006932812,0.00001643732,0.001913521],"genre_scores_gemma":[0.1531161,0.8387079,0.00260026,0.002556361,0.0004244469,0.00128484,0.0007727902,0.000009468517,0.000527825],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005832344,"threshold_uncertainty_score":0.02828419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045278212","doi":"10.1097/00002826-200403000-00004","title":"Dopaminergic Properties and Experimental Anti-Parkinsonian Effects of IPX750 in Rodent Models of Parkinson Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Dopaminergic; Dopamine transporter; Dopamine; Pharmacology; Chemistry; Dopamine Plasma Membrane Transport Proteins; Agonist; Biochemistry; Biology; Receptor; Neuroscience","authors":[{"name":"Chuantao Jiang","is_ca":false},{"name":"Xinhua Wan","is_ca":false},{"name":"Joseph Jankovic","is_ca":false},{"name":"Samuel T. Christian","is_ca":false},{"name":"Zdenek B. Pristupa","is_ca":true},{"name":"Hyman B. Niznik","is_ca":true},{"name":"John S. Sundsmo","is_ca":false},{"name":"Weidong Le","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0680360821334167,"gpt":0.3304043789368377,"spread":0.262368296803421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003592796,0.001079801,0.0004386262,0.001074878,0.0003814146,0.000397458,0.0004716165,0.000703626,0.002491859],"category_scores_gemma":[0.0001564893,0.0002856685,0.0005459077,0.0003420023,0.000615374,0.0005422183,0.0001507905,0.001488776,0.0004996443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007297773,"about_ca_system_score_gemma":0.0004716648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002366941,"about_ca_topic_score_gemma":0.005918987,"domain_scores_codex":[0.9997565,0.0000338723,0.00002530172,0.00004832666,0.00006324559,0.00007278899],"domain_scores_gemma":[0.9998327,0.00001381813,0.00005200134,0.00001801035,0.00001847625,0.00006494448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002778296,0.002193793,0.0005817807,0.0002473482,0.00006087951,0.0002641917,0.00007906024,0.0002022497,0.9854139,0.0003236376,0.0004868729,0.007368034],"study_design_scores_gemma":[0.0004533133,0.02593154,0.0115853,0.00004511316,0.000189833,0.0005351891,0.000138722,0.001091834,0.9551998,0.0001830372,0.004618898,0.00002741907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860368,0.005591888,0.001657885,0.0002972701,0.0001235706,0.0002459638,0.002036664,0.0001972217,0.003812677],"genre_scores_gemma":[0.9728812,0.006810513,0.003190786,0.0002156842,0.00008027956,0.0004523969,0.003749335,0.00003489412,0.01258483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002491859,"threshold_uncertainty_score":0.008336127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068802937","doi":"10.1097/00002826-200601000-00010","title":"Somatic Augmentation Strategies in Clozapine Resistance-What Facts?","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Clozapine; Polypharmacy; Tolerability; Medicine; Electroconvulsive therapy; Rotigotine; Clinical trial; Transcranial magnetic stimulation; Psychiatry; Psychology; Pharmacology; Adverse effect; Internal medicine; Stimulation; Disease; Schizophrenia (object-oriented programming)","authors":[{"name":"Constantin Tranulis","is_ca":true},{"name":"Fayçal Mouaffak","is_ca":false},{"name":"Laurent Chouchana","is_ca":false},{"name":"Émmanuel Stip","is_ca":true},{"name":"Raphaël Gourévitch","is_ca":false},{"name":"Marie Poirier","is_ca":false},{"name":"Jean‐Pierre Olié","is_ca":false},{"name":"Henri Lôo","is_ca":false},{"name":"David Gourion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1426187868477103,"gpt":0.5178340429518419,"spread":0.3752152561041315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001079668,0.0005733895,0.001724034,0.001447798,0.0002075514,0.0009646271,0.0008934763,0.001566877,0.003860104],"category_scores_gemma":[0.002017946,0.0002266164,0.000768088,0.001894781,0.0004518911,0.001191115,0.000288719,0.000714139,0.0009519954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005161872,"about_ca_system_score_gemma":0.001090357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001985883,"about_ca_topic_score_gemma":0.005328835,"domain_scores_codex":[0.9996383,0.0001385354,0.00008368419,0.00003056748,0.00008756939,0.00002132158],"domain_scores_gemma":[0.9993,0.0004480475,0.0001424828,0.00001739878,0.00007304044,0.0000190767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003071827,0.00006710066,0.0003378755,0.07410108,0.0003184164,0.0006274109,0.0001369835,0.0001356734,0.000599286,0.001240701,0.007906823,0.9142215],"study_design_scores_gemma":[0.001074746,0.001186537,0.01042055,0.1821539,0.004059154,0.01841724,0.001539423,0.0004047938,0.002112086,0.004546217,0.7739962,0.00008920916],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000229894,0.9990554,0.00002001223,0.0002816878,0.0000502415,0.000003580017,0.000004816493,0.000002012289,0.0003522861],"genre_scores_gemma":[0.00236323,0.9970387,0.0001213671,0.000218991,0.00009198561,0.000008681322,0.000008239244,6.231951e-7,0.000148165],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003860104,"threshold_uncertainty_score":0.01291335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032203345","doi":"10.1097/wnf.0b013e3181f8d4ed","title":"Evidence for Use of Mood Stabilizers and Anticonvulsants in the Treatment of Nonaffective Disorders in Children and Adolescents","year":2010,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Hotel Dieu Hospital","funders":"","keywords":"Mood; Mood disorders; Lithium (medication); Psychiatry; Mood stabilizer; Divalproex; Anticonvulsant; Psychology; Bipolar disorder; Lamotrigine; Clinical psychology; Medicine; Mania; Anxiety; Epilepsy","authors":[{"name":"Alfred Amaladoss","is_ca":true},{"name":"Nasreen Roberts","is_ca":false},{"name":"Franklin Amaladoss","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1707224189536841,"gpt":0.4752191105979739,"spread":0.3044966916442898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001817232,0.0005494763,0.001773273,0.002850315,0.0001992394,0.0009462594,0.0008594667,0.0009410367,0.003392542],"category_scores_gemma":[0.00389805,0.0003143307,0.001197908,0.0031692,0.000447672,0.0006049555,0.0004584875,0.0008192121,0.0005000591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006025422,"about_ca_system_score_gemma":0.002039892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002442494,"about_ca_topic_score_gemma":0.005447177,"domain_scores_codex":[0.9991069,0.0002552993,0.0002704925,0.00009291585,0.0002404113,0.00003386863],"domain_scores_gemma":[0.9971049,0.001947109,0.0006000456,0.00003478202,0.0002590406,0.00005413126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002731028,0.00007584754,0.002075286,0.1946755,0.001361504,0.0006104386,0.0001633558,0.0001396059,0.0009247818,0.000899281,0.006411326,0.79239],"study_design_scores_gemma":[0.000381088,0.0008645861,0.0376592,0.4043958,0.0122119,0.01135192,0.0007906274,0.0001427263,0.001968729,0.001529165,0.5286448,0.00005944562],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000167151,0.9995122,0.00001038063,0.0000654071,0.00002002195,0.000002308739,0.000008535686,8.14044e-7,0.0002131648],"genre_scores_gemma":[0.001648109,0.9981216,0.00008034646,0.00007342244,0.00002124864,0.000003769116,0.00001062849,4.6555e-7,0.00004043322],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003392542,"threshold_uncertainty_score":0.0113492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087720405","doi":"10.1097/wnf.0000000000000034","title":"Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth","year":2014,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders; University of Toronto","funders":"","keywords":"Levodopa; Small intestinal bacterial overgrowth; Bacterial overgrowth; Medicine; Parkinson's disease; Gastroenterology; Disease; Internal medicine","authors":[{"name":"Alfonso Fasano","is_ca":true},{"name":"Francesco Bove","is_ca":false},{"name":"Maurizio Gabrielli","is_ca":false},{"name":"Enzo Ragazzoni∘","is_ca":false},{"name":"Serena Fortuna","is_ca":false},{"name":"Annalisa Tortora","is_ca":false},{"name":"Maria Assunta Zocco","is_ca":false},{"name":"Stefano Marconi","is_ca":false},{"name":"Antonio Gasbarrini","is_ca":false},{"name":"Anna Rita Bentivoglio","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03021068418300843,"gpt":0.3101651354656374,"spread":0.279954451282629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004243719,0.0003264706,0.000992373,0.0001759646,0.00025061,0.0003142225,0.000159619,0.0003897935,0.001272043],"category_scores_gemma":[0.001029345,0.0001230904,0.0004970448,0.0001426235,0.0002052995,0.0003035438,0.0002150663,0.0004082612,0.0001396326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002675201,"about_ca_system_score_gemma":0.0002655271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004608252,"about_ca_topic_score_gemma":0.001196345,"domain_scores_codex":[0.9998149,0.00007656625,0.00002631257,0.00002863684,0.00002695508,0.00002664003],"domain_scores_gemma":[0.9995011,0.0001953515,0.00009328312,0.0000161506,0.00002360765,0.0001705476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7140384,0.008227832,0.1450207,0.0006298779,0.001152612,0.0006401526,0.0003713509,0.0006534465,0.01860248,0.00008062567,0.0005374833,0.1100449],"study_design_scores_gemma":[0.03940613,0.4635772,0.4837877,0.0001336147,0.001486142,0.001304278,0.0005764347,0.003373716,0.004366815,0.0001662974,0.001769542,0.00005225511],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998682,0.00104406,0.00002318996,0.00003210363,0.000009855507,0.00001600094,0.00002642445,0.000003056327,0.0001632087],"genre_scores_gemma":[0.9993516,0.0002700545,0.0001167345,0.00004989402,0.00001942908,0.0000265484,0.00006080959,7.074247e-7,0.0001043602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001272043,"threshold_uncertainty_score":0.004255414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051115769","doi":"10.1097/00002826-200107000-00004","title":"Comparison of Two Dosages of Tolcapone Added to Levodopa in Nonfluctuating Patients with PD","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital de l'Enfant-Jésus; Roche (Canada); University of Calgary; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Dose; Adverse effect; Levodopa; Nausea; Crossover study; Medicine; Dyskinesia; Tolerability; Anesthesia; Placebo; Internal medicine; Parkinson's disease; Disease","authors":[{"name":"Oksana Suchowersky","is_ca":true},{"name":"Peter Bailey","is_ca":true},{"name":"Emmanuelle Pourcher","is_ca":true},{"name":"Lynne Bulger","is_ca":true},{"name":"Giovanni Facciponte","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07501022924080697,"gpt":0.4547305578632965,"spread":0.3797203286224896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001195258,0.001111272,0.002532288,0.000664809,0.0003986385,0.0009288074,0.0009444206,0.001598577,0.002737098],"category_scores_gemma":[0.002671438,0.0006925655,0.00116303,0.0004251002,0.0008867511,0.001020446,0.0003323136,0.002014691,0.0004555056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006397671,"about_ca_system_score_gemma":0.0004960499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006182448,"about_ca_topic_score_gemma":0.001675162,"domain_scores_codex":[0.9990195,0.0005025078,0.0001004246,0.0001656698,0.0001021446,0.0001097049],"domain_scores_gemma":[0.9985489,0.0005508095,0.0002547161,0.0001088949,0.00007305984,0.0004635539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9400276,0.01345169,0.002018847,0.0004177523,0.0006877411,0.0001581337,0.0001131863,0.0003009835,0.006684811,0.0000710606,0.0002241176,0.03584402],"study_design_scores_gemma":[0.5685627,0.4205204,0.00832774,0.00003463341,0.0003705827,0.0001109805,0.000059365,0.0004467773,0.001012892,0.00007490032,0.0004467673,0.00003226154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966815,0.002066338,0.0001382241,0.0001009505,0.0001130643,0.0003045383,0.0001315939,0.00003009095,0.0004337255],"genre_scores_gemma":[0.9971865,0.0009795739,0.0004180337,0.0001760277,0.0001936951,0.0003181879,0.0002912826,0.000006473409,0.0004302741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002737098,"threshold_uncertainty_score":0.009156525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085470371","doi":"10.1097/00002826-200307000-00007","title":"Pharmacokinetic Studies of Single and Multiple Oral Doses of Fampridine-SR (Sustained-Release 4-Aminopyridine) in Patients With Chronic Spinal Cord Injury","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Lawson Health Research Institute; Western University","funders":"","keywords":"Pharmacokinetics; 4-Aminopyridine; Medicine; Dosing; Spinal cord injury; Adverse effect; Anesthesia; Oral administration; Spinal cord; Pharmacology; Internal medicine","authors":[{"name":"Keith C. Hayes","is_ca":true},{"name":"Patrick J. Potter","is_ca":true},{"name":"Robert R. Hansebout","is_ca":true},{"name":"J Bugaresti","is_ca":true},{"name":"Jane Hsieh","is_ca":true},{"name":"Sera Nicosia","is_ca":true},{"name":"Mitchell A. Katz","is_ca":false},{"name":"Andrew R. Blight","is_ca":false},{"name":"Ron Cohen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1136157444778536,"gpt":0.4635978927958428,"spread":0.3499821483179892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008574259,0.0004692171,0.001331385,0.0002734215,0.0003260865,0.0003945668,0.0002298527,0.0006473039,0.0008023194],"category_scores_gemma":[0.002816745,0.0002787109,0.0005023731,0.0003448136,0.000444847,0.0004661566,0.0001635678,0.0009345431,0.0002581255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004308326,"about_ca_system_score_gemma":0.0006337801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008811204,"about_ca_topic_score_gemma":0.0008220961,"domain_scores_codex":[0.9994961,0.0002197814,0.00004246727,0.00009670204,0.00009805004,0.00004692198],"domain_scores_gemma":[0.9987871,0.0003713744,0.000329863,0.00008982282,0.0001323223,0.0002895932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2682038,0.01408479,0.1137066,0.001233663,0.002529145,0.00201606,0.001793492,0.005656604,0.3379458,0.0003198543,0.002287071,0.2502232],"study_design_scores_gemma":[0.02866431,0.5416763,0.3728507,0.00007476415,0.001324173,0.005262908,0.0003839084,0.008742353,0.03403828,0.0002210404,0.006613956,0.0001472615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963564,0.0021349,0.0007311237,0.00007090664,0.00001797685,0.0001108691,0.0001371831,0.00003168898,0.0004089482],"genre_scores_gemma":[0.9973536,0.0009041433,0.0008438745,0.0001205892,0.00006158778,0.0001465114,0.0002775419,0.000008875412,0.0002832659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001331385,"threshold_uncertainty_score":0.004534543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085751814","doi":"10.1097/01.wnf.0000220823.80640.44","title":"Topiramate-induced Psychosis in Patients with Essential Tremor","year":2006,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Topiramate; Paranoia; Psychosis; Psychiatry; Medicine; Essential tremor; Adverse effect; Psychology; Pediatrics; Epilepsy; Internal medicine","authors":[{"name":"Theresa Zesiewicz","is_ca":true},{"name":"Archer Tullidge","is_ca":false},{"name":"Jonathan Tidwell","is_ca":false},{"name":"Kelly L. Sullivan","is_ca":true},{"name":"Robert A. Hauser","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02673696237727847,"gpt":0.3604325734656091,"spread":0.3336956110883307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003306816,0.0005154914,0.000519945,0.0005781053,0.0008408389,0.0005292771,0.0002540091,0.0007676646,0.0009381374],"category_scores_gemma":[0.002297836,0.0003990991,0.0006490156,0.0003660274,0.000363028,0.0004246997,0.0003362012,0.0008104684,0.0002015219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006440296,"about_ca_system_score_gemma":0.0004941659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002943177,"about_ca_topic_score_gemma":0.005580295,"domain_scores_codex":[0.9996576,0.00007785547,0.00005039399,0.00003369537,0.00008194509,0.0000984591],"domain_scores_gemma":[0.9994374,0.0001744568,0.0001434488,0.00003057894,0.00003889517,0.0001752769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.007150313,0.0009295975,0.7227741,0.0003660209,0.0003123755,0.1980968,0.002819113,0.0005125056,0.01636833,0.0003694222,0.001122254,0.04917913],"study_design_scores_gemma":[0.001442622,0.006053105,0.7727864,0.0001081593,0.0004343034,0.2109208,0.001273414,0.001756359,0.002333076,0.0005842968,0.002230888,0.0000765869],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966841,0.0008260535,0.0001606804,0.0001993487,0.00001925022,0.00004360943,0.00004198067,0.00001740106,0.002007474],"genre_scores_gemma":[0.9994072,0.0002285219,0.00007357136,0.0001056344,0.00001954725,0.000005615655,0.00003199144,0.000001569868,0.0001264422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002943177,"threshold_uncertainty_score":0.005852103,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3013161772","doi":"10.1097/wnf.0000000000000384","title":"Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series","year":2020,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Venlafaxine; Mirtazapine; Mianserin; Parkinsonism; Psychosis; Psychiatry; Escitalopram; Randomized controlled trial; Medicine; Antipsychotic; Citalopram; Ziprasidone; Anticholinergic; Psychology; Antidepressant; Schizophrenia (object-oriented programming); Disease; Internal medicine; Anxiety","authors":[{"name":"Lamia Sid‐Otmane","is_ca":true},{"name":"Philippe Huot","is_ca":true},{"name":"Michel Panisset","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05376582530136106,"gpt":0.4460727770714156,"spread":0.3923069517700546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006344319,0.001163721,0.001743033,0.00524003,0.000503678,0.0008432612,0.001141291,0.001125742,0.002979041],"category_scores_gemma":[0.002604116,0.0003946345,0.001228531,0.005335165,0.0006428111,0.001155749,0.0006303401,0.0007230293,0.0007010879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005689969,"about_ca_system_score_gemma":0.001211107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001458281,"about_ca_topic_score_gemma":0.002959451,"domain_scores_codex":[0.9992959,0.0001048856,0.0003302543,0.00009921624,0.0001302686,0.00003933203],"domain_scores_gemma":[0.9983919,0.0009162051,0.0004235939,0.00006363181,0.0001563475,0.0000482799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002753834,0.0001243505,0.004881633,0.1548255,0.001272969,0.03759616,0.0007516664,0.000424084,0.002181638,0.00112365,0.01984088,0.776702],"study_design_scores_gemma":[0.0001611261,0.0004893275,0.02203972,0.1151801,0.007019997,0.4680059,0.001293916,0.0002249521,0.001990488,0.002035438,0.3814083,0.0001507218],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006365502,0.998718,0.00007506686,0.00007932655,0.00005801048,0.00001045186,0.00002658187,0.000004703012,0.0003912815],"genre_scores_gemma":[0.00931799,0.9897454,0.000278922,0.0002175207,0.0001622542,0.00001688792,0.00006348841,0.000002986902,0.0001945781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00524003,"threshold_uncertainty_score":0.009965897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987370838","doi":"10.1097/wnf.0b013e31815cba61","title":"Variability of the In Vivo Metabolism of Clozapine","year":2008,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Defense Medical College","keywords":"Clozapine; Metabolite; In vivo; Schizophrenia (object-oriented programming); Pharmacology; Antipsychotic; Atypical antipsychotic; Metabolism; Psychology; Chemistry; Endocrinology; Internal medicine; Medicine; Biology; Psychiatry","authors":[{"name":"Thomas J. Raedler","is_ca":true},{"name":"Kim Hinkelmann","is_ca":false},{"name":"Klaus Wiedemann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07665838262348112,"gpt":0.4100766655505208,"spread":0.3334182829270397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009415461,0.0002873419,0.0003979662,0.0003098173,0.0001852922,0.0005892761,0.0001938422,0.0003559008,0.0007847198],"category_scores_gemma":[0.003035628,0.0001823092,0.0002028312,0.0003238555,0.0002877832,0.0001492975,0.0001993045,0.0003176929,0.0002982421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002428498,"about_ca_system_score_gemma":0.0001131092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001284577,"about_ca_topic_score_gemma":0.001059462,"domain_scores_codex":[0.9984488,0.0006421512,0.0001410317,0.000400183,0.0003145636,0.00005311416],"domain_scores_gemma":[0.9979116,0.0009647134,0.0004208799,0.0004176823,0.0002314704,0.00005351868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008686177,0.000340803,0.6076797,0.0002836162,0.001922444,0.0003857446,0.0008542699,0.00245993,0.3222173,0.0002557585,0.0007159528,0.05419834],"study_design_scores_gemma":[0.00007138122,0.00115295,0.9386,0.00001344333,0.0002651479,0.001549875,0.0001094003,0.00311389,0.05322242,0.000170327,0.001702973,0.00002808684],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931558,0.0009652124,0.004344388,0.00003208366,0.00001946522,0.00003320791,0.0005167853,0.00006781878,0.0008652785],"genre_scores_gemma":[0.9983252,0.0001257177,0.0007622,0.00002341745,0.00001198403,0.00001915715,0.0005197307,0.00001361433,0.0001989045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001284577,"threshold_uncertainty_score":0.004979432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2396912542","doi":"10.1097/wnf.0000000000000107","title":"Comparison Between Dysport and Prosigne in the Treatment of Cervical Dystonia","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Dystonia; Medicine; Dermatology; Pediatrics; Psychiatry","authors":[{"name":"Pedro Barbosa","is_ca":false},{"name":"Daniel Sabino de Oliveira","is_ca":false},{"name":"Carolina Pinto Souza","is_ca":false},{"name":"Vítor Tumas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2095311718629328,"gpt":0.4772698150497375,"spread":0.2677386431868047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586961,0.0003656625,0.001012015,0.0003697433,0.0001973001,0.0003405376,0.0003679332,0.0005434647,0.001457375],"category_scores_gemma":[0.001658083,0.0001593984,0.0005639193,0.0002505859,0.0005238236,0.0003429023,0.0002771034,0.0003638564,0.00009988668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004276965,"about_ca_system_score_gemma":0.0004404209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006384663,"about_ca_topic_score_gemma":0.001756136,"domain_scores_codex":[0.9988299,0.0007070079,0.0001438199,0.0001056227,0.0001524769,0.00006107832],"domain_scores_gemma":[0.9987803,0.0004595403,0.0004467543,0.00006035527,0.00009050642,0.000162549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6707191,0.0163512,0.01927795,0.00372365,0.003789944,0.0002591611,0.0003828514,0.001145573,0.03234306,0.0003801072,0.0002506226,0.2513767],"study_design_scores_gemma":[0.1122258,0.8143617,0.06266443,0.0002118753,0.001926973,0.0004359015,0.0001689308,0.0006114087,0.005087465,0.0001306414,0.002141198,0.00003362908],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950455,0.004256909,0.00009709926,0.00005094102,0.00002150273,0.0001700518,0.00002806242,0.000005495762,0.0003244427],"genre_scores_gemma":[0.9968706,0.002031818,0.0004842702,0.00009073293,0.00005720774,0.00015951,0.00007633815,0.000001589713,0.0002279938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001586961,"threshold_uncertainty_score":0.008392751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2329026659","doi":"10.1097/wnf.0000000000000067","title":"Effect of Midazolam on Memory During Fiberoptic Gastroscopy Under Conscious Sedation","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Midazolam; Sedation; Anesthesia; Medicine","authors":[{"name":"Yun Jeong Hong","is_ca":false},{"name":"Eun Hye Jang","is_ca":false},{"name":"Jihye Hwang","is_ca":false},{"name":"Jee Hoon Roh","is_ca":false},{"name":"Miseon Kwon","is_ca":false},{"name":"Don Lee","is_ca":false},{"name":"Jae‐Hong Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06420667134097428,"gpt":0.4356038684814592,"spread":0.3713971971404849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001688557,0.0001827339,0.0002496421,0.0001024337,0.0001188831,0.0002240929,0.0001153925,0.0001776228,0.0006413562],"category_scores_gemma":[0.00136806,0.00005911196,0.0001317733,0.00007278677,0.0002026918,0.0001708267,0.0001499793,0.0002325526,0.00005744739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001618407,"about_ca_system_score_gemma":0.0002137367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006721552,"about_ca_topic_score_gemma":0.001018864,"domain_scores_codex":[0.9998816,0.0000390816,0.00001131962,0.0000126907,0.00002645781,0.00002883544],"domain_scores_gemma":[0.9995492,0.0001291348,0.0001627064,0.00002928884,0.00005594847,0.00007368793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.07822985,0.002978727,0.1917894,0.0008352097,0.0003714508,0.003088961,0.001364594,0.0003033457,0.5769817,0.0001334533,0.0004232663,0.1435002],"study_design_scores_gemma":[0.0008254917,0.065883,0.8630459,0.00006346936,0.0003094774,0.002114676,0.0004477234,0.0009376548,0.06524748,0.00007704132,0.001025316,0.00002283936],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993299,0.0003953295,0.00004377614,0.00001323699,0.000004713879,0.000007877829,0.0000094959,0.000003544452,0.0001921204],"genre_scores_gemma":[0.9996755,0.0001387664,0.00005709111,0.00002006647,0.000005476721,0.000005494875,0.00001750182,6.300683e-7,0.00007949527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006721552,"threshold_uncertainty_score":0.002145529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4309181475","doi":"10.1097/wnf.0000000000000528","title":"Protective Effects of Ursodeoxycholic Acid Against Oxidative Stress and Neuroinflammation Through Mitogen-Activated Protein Kinases Pathway in MPTP-Induced Parkinson Disease","year":2022,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"MPTP; Ursodeoxycholic acid; Oxidative stress; Pharmacology; Neuroinflammation; Superoxide dismutase; Chemistry; Endocrinology; p38 mitogen-activated protein kinases; Internal medicine; Kinase; Medicine; Dopamine; Protein kinase A; Biochemistry; Inflammation; Dopaminergic","authors":[{"name":"Chenggong Jiang","is_ca":false},{"name":"Dongfang Shen","is_ca":false},{"name":"Kaiyang Li","is_ca":true},{"name":"Huan Wang","is_ca":false},{"name":"Wenxu Sang","is_ca":false},{"name":"Huiping Qi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03706120007032836,"gpt":0.3400274841243841,"spread":0.3029662840540557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001308167,0.0004193622,0.000530728,0.0004567189,0.0002175585,0.0001855222,0.0001991647,0.0003332022,0.0007129214],"category_scores_gemma":[0.0001476504,0.0001305499,0.0003319004,0.0002258305,0.0002605596,0.0003750415,0.0002212358,0.0005063547,0.0001159241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001207673,"about_ca_system_score_gemma":0.0002485887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002675805,"about_ca_topic_score_gemma":0.0004789337,"domain_scores_codex":[0.9999332,0.00001420635,0.00001087989,0.00001228897,0.00001311502,0.00001624723],"domain_scores_gemma":[0.9999301,0.000004506747,0.00002292252,0.000005462622,0.00001422651,0.00002285703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003959485,0.0005319421,0.001582777,0.0008826822,0.0001168766,0.0003288213,0.00008070812,0.0002193253,0.9735259,0.000189399,0.0002444705,0.01833762],"study_design_scores_gemma":[0.0007901881,0.007741005,0.0334148,0.0001773824,0.0004572203,0.001121563,0.0002138957,0.001832869,0.9416443,0.0005331296,0.01204005,0.00003359281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9613113,0.03476741,0.001954587,0.000331834,0.0001135403,0.00006324304,0.0002584679,0.0001039991,0.001095587],"genre_scores_gemma":[0.9846345,0.0120394,0.001819344,0.0001333513,0.00004389544,0.00008276662,0.0002799724,0.00000993307,0.0009568547],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007129214,"threshold_uncertainty_score":0.00238502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}